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Trypanosoma brucei, a unicellular eukaryotic parasite, is the causative agent of 
African sleeping sickness in sub-Saharan Africa.   The parasite encounters two main 
environments as it progresses through its life cycle:  the tsetse fly and the mammalian 
bloodstream.  Nutrient availability is distinct in the two environments, requiring the 
parasite to utilize diverse metabolic pathways to efficiently produce ATP for survival.  
Bloodstream form parasites (BSF), residing in a glucose rich environment, rely solely on 
glycolysis for energy, while procyclic form (PF) parasites metabolize readily available 
proline and threonine in addition to glucose. 
T. brucei expresses two hexokinases, the first enzyme in the glycolytic pathway, 
that are 98.5% identical at the nucleotide level and 98% similar at the amino acid level.  
These two enzymes, TbHK1 and TbHK2, are differentially expressed in both BSF and PF 
parasites.  Here, I identify a means of regulation of TbHK1 gene expression and a novel 
mechanism for regulating TbHK1 enzyme activity.  Lastly, I have characterized, the 
bioflavonoid quercetin, a small molecule regulator TbHK1. 
Mechanisms involved in regulating TbHK1 and TbHK2 gene expression have not 
been extensively studied.  I have found that TbHK1 uses differential polyadenylation to 
regulate gene expression in variable environmental conditions.  A recent study by Siegel 
et al. (2010), revealed that TbHK1 contains seven predominant polyadenylation sites, 
whereas, TbHK2 contains only one.  Using a reporter gene system to assess transcript 
level and protein expression, I have determined that these seven different 3’UTR lengths 
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result in differential steady state transcript abundance and expression level, dependent on 
nutrient availability. 
Further, I have identified a novel means of regulation of TbHK1 enzyme activity.   
Enzymatic studies of recombinant TbHK1 reveal that TbHK is inactivated under acidic 
conditions.  However, the addition of glycerol-3-phosphate to the reaction at acidic pH 
maintained T. brucei hexokinase activity.   I propose this regulation may play an 
important role in the biology of the parasite during differentiation and subsequent 
acidification of glycosomes, the peroxisomal like organelle that houses glycolytic 
enzymes. 
Lastly, the TbHKs were identified as possible drug targets because they are 
essential to the BSF parasite and only ~30% similar to human glucokinase, the human 
equivalent of TbHK1. We have found that quercetin, a known trypanocide, is a potent 
inhibitor of TbHK1.  Further, taking advantage of the fluorescent nature of the 
compound, I found that the compound localizes to the same subcellular compartment that 
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Trypanosoma brucei, a single-celled eukaryotic parasite, is the causative agent of African 
sleeping sickness, affecting 50-70,000 people in 36 countries of sub-Saharan Africa (Brun, 
2010).  There are three subspecies of T. brucei: T. brucei brucei, T. brucei rhodesiense, and T. 
brucei gambiense, with the latter two subspecies being infective to humans.  T. b. gambiense is 
endemic to west and central Africa and causes a chronic form of trypanosomiasis, whereas T. b. 
rhodesiense is prevalent in east and southern Africa and causes an acute form of the disease.  T. 
b. brucei is not infective to humans, but instead infects wild and domestic animals causing a 
disease termed nagana  (Brun et al., 2010).    
The parasite is transmitted to the mammalian host by the bite of an infected tsetse fly 
(Glossina genus) (Jordan, 1993).  Upon transmission from the fly into the bloodstream of the 
human host, the parasite lives and divides, with the first signs of infection being fever and joint 
pain.  Currently, treatment is available for this stage of trypanosomiasis, however, it is often 
undiagnosed and in turn untreated (Doua et al., 1996).  If left untreated, the parasite load 
increases in the infected individual and eventually crosses the blood-brain barrier and infects the 
central nervous system causing symptoms such as disturbance in sleep patterns and confusion 
(Buguet et al., 2006; Kennedy, 2006).  Trypanosome infection is always fatal if left untreated 
(Brun et al., 2010).  Treatment currently available for this stage of the disease is toxic, killing up 
to 10% of patients and requires high doses typically delivered by intravenous administration over 
several days to be effective (Schmid et al., 2005).  
According to the World Health Organization, African sleeping sickness is considered a 
neglected tropical disease and remains an important public health issue (Brun et al., 2010).  As 
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aforementioned, treatments currently available for African sleeping sickness are toxic and hard 
to administer, therefore, identification of potential drug targets to develop alternative therapeutic 
options for treatment of trypanosomiasis is a priority of research.  Current T. brucei research, 
however, is not only focused on elucidating a treatment for disease, but also understanding the 
cell biology of the organism, including cell structure, organelle positioning, protein trafficking 
and cell division (Matthews, 2005) – these efforts may identify new targets for therapeutic 
development. 
 
I.  LIFE CYCLE OF T. BRUCEI 
T. brucei spends its life in two distinct environments:  the tsetse fly or the mammalian 
host.  The nutrient availability and overall environments are different in the host and vector, 
requiring the organism to adapt to new biological niches as it transverses through the various life 
cycle stages (Figure 1.1).  
Upon the bite of an infected tsetse fly, infective metacyclic T. brucei differentiate into 
long slender bloodstream forms (BSF) where they proliferate extracellularly in the bloodstream 
of the mammalian host.  In the glucose rich bloodstream, metabolism is accomplished solely 
through glycolysis, as BSF parasites harbor a mitochondrion that is cryptic and not fully 
functional (Priest and Hajduk, 1994).  The surface of BSF parasites is arrayed with 
glycophosphatidylinositol (GPI)-anchored variant surface glycoproteins (VSGs) that aid in 
evading the immune response of the host (Horn, 2001).   Antigenic variation of the VSGs is 
utilized by the parasite, which has a repertoire of > 1000 VSG genes that it can switch 





Figure 1.1  Simplified life cycle of T. brucei.   
Long slender parasites proliferate in the mamammalian bloodstream. In preparation for life in the tsetse 
fly, BSF parasites differentiate into non-proliferative short stumpy form.  Once taken up by the bite of a 
tsetse fly, the parasites morph into procyclic form parasites and rapidly divide in the midgut of the fly.  To 
complete the life cycle, the parasites transition into non-dividing metacyclic forms, residing in the tsetse 
fly salivary gland.  The parasites begin the life cycle again when they are transmitted back into the 
bloodstream of a mammalian host. (Image from: A fatty-acid synthesis mechanism specialized for 
parasitism.  Lee, SH, Jennifer L. Stephens & Paul T. Englund Nature Reviews Microbiology 5, 287-297 
April 2007.  Permission granted for use of figure.)   
 
Once BSF parasites reach a high density in the blood, a portion of the cells differentiate 
into stumpy form parasites in preparation for the bite of a tsetse fly (Vickerman, 1985, 1965).  
The mechanisms controlling the differentiation of BSF to stumpy form parasites are not clearly 
understood.  Experimentally it has been determined, however, that long slender forms produce a 
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stumpy induction factor (SIF) to signal the switch.  The identity and mechanism of SIF is 
currently unknown (MacGregor and Matthews, 2010).   
As BSFs transition to stumpy forms many changes occur in the biology of the parasite.  
Stumpy forms are non-proliferative, cell cycle arrested, and have a more active mitochondrion to 
prepare them for the low glucose environment that they will soon encounter in the fly (Bass and 
Wang, 1991).  Stumpy forms are arrested in the G1 stage of the cell cycle, making certain that 
changes that occur during transmission into the tsetse fly are coordinated with the resumption of 
the cell cycle (Ziegelbauer et al., 1990).  The protein surface coat on the stumpy form remains 
the same as that of the long slender form, VSG, and is shed and replaced only after taking up 
residence in the tsetse fly (Matthews, 2005). 
After a fly consumes a blood meal from an infected host, the stumpy form parasites 
transition to procyclic forms (PF) in the midgut of the fly.  A heterogeneous population of 
trypanosomes consisting of BSFs and stumpy forms is consumed in the initial blood meal.  
Stumpy form parasites are able to survive the stresses in the harsh environment of the tsetse fly, 
while slender BSFs are not (Nolan et al., 2000).  Short stumpy forms have developed 
mechanisms to adapt to the abrupt environmental, nutrient and temperature changes.  Until 2009, 
the trigger that cued stumpy forms to switch to PFs remained elusive.  However, it is now known 
that stumpy forms express a family of proteins, proteins associated with differentiation (PAD), 
that can sense the drop in temperature from the mammal (37°C) to the tsetse fly (20°C) which 
triggers the switch to the procyclic form parasite (Dean et al., 2009).    
PFs rapidly divide in the tsetse fly gut displaying gross biological differences, including 
mitochondrial development and organelle positioning, compared to BSFs and short stumpy 
forms.  These differences allow for survival in the glucose deplete environment of the tsetse fly.  
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To this end, PF parasites exhibit an active mitchodrion with components required for a functional 
Krebs cycle and electron transport chain.  This elaboration of metabolic pathways permits PFs to 
metabolize amino acids, rather than solely glucose, for ATP production (Priest and Hadjuk, 
1994).  
During differentiation between stumpy forms and PFs, the VSG surface coat is replaced 
by new set of surface proteins called procyclins (Roditi and Clayton, 1999).  Procyclins, like 
VSGs, are GPI anchored (Roditi et al., 1989).  These surface proteins are characterized by their 
internal repeat motifs which consist of either repeats of glutamic acid-proline called EP, or 
repeats of 6 peptides (gly-pro-glu-glu-thr) termed GPEET (Roditi and Clayton, 1999). After PFs 
have sufficiently proliferated in the midgut, a portion of the parasites move to the salivary gland 
where they differentiate into the proliferative epimastigote form and attach to the salivary gland 
wall through changes made in their flagellar structure (Van Den Abbeele et al., 1999; Sharma et 
al., 2009).  In preparation for infection of mammals, the parasites mature through one last 
developmental stage, the metacylic form, in which the surface coat is switched back to VSG and 
division is arrested (Van Den Abbeele et al., 1999).  After differentiating to metacyclics, the 
parasites are prepared to infect a new host and repeat the life cycle.   The process for PF parasites 
to progress to the metacyclic stage and become competent to infect a mammal takes ~3-5 weeks 
(Fenn and Matthews, 2007).                                  
 
II.  CELL STRUCTURE AND BIOLOGY 
 Trypanosomes are single celled protozoa classified as kinetoplastids.  T.  brucei, are 
microscopic and dependent on life cycle stage, range in size from 12-35 µM (Rotureau et al., 
2011).  The cell body of the parasite is organized in such a fashion that as it progresses through 
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the life cycle, single copy organelles of the cell (flagellar pocket, flagellum, kinetoplast, 
mitochondrion, and nucleus) can divide and differentiate efficiently (Matthews, 2005).   An 
elongated and highly polarized microtubule cytoskeleton defines the shape of the parasite 
(Robinson et al., 1995). (Fig.1.2) 
 
Figure 1.2 Schematic representation of the cellular organization of T. brucei.   
T. brucei contain typical organelles found in eukaryotic cells.  To note, T. brucei also contain unique 
organelles including the kinetoplast, flagellar pocket and glycosomes.  (Adapted from: Overath, P. and 
Engstler, M.  2004. Endocytosis, membrane recycling and sorting of GPI-anchored proteins: 
Trypanosoma brucei as a model system.  Molecular Microbiology  53: 735-744.  Permission granted for 
use of figure.) 
 
A single flagellum arises out of the basal body near the posterior end of the cell and 
extends a short distance past the length of the cell (Ralston et al., 2009).  T.  brucei rely on their 
flagellum for motility, attachment to the tsetse fly salivary gland prior to transmission, and for a 
wide array of other cellular functions including proper cell division.   The flagellum consists of a 
conventional axonemal structure (9+2 arrangement of microtubules) plus an associated 
paraflagellar rod, which contributes further to the motility of the organism (Vickerman, 1962; 
Kinetoplast Endosomes 
 
  Nucleus 
Mitochondrion 
Flagellum 


















Bastin and Gull, 1999).  This organelle remains in close proximity to the cell via the flagellar 
attachment zone (FAZ), which includes a group of cytoskeletal and membranous attachments 
(Portman and Gull, 2010).   Also important in the flagellar structure is the flagellar pocket, an 
invagination formed at the site where the flagellum emerges from the basal body (Ralston et al., 
2009).  The flagellar pocket is the only site of endocytosis or exocytosis for T.  brucei (Overath 
and Engstler, 2004; Morgan et al., 2002).  
All kinetoplastida contain a single mitochondrion.  The mitochondrion function and 
development in T. brucei varies greatly, dependent on life cycle stage (Van Hellemond et al., 
2005).  T. brucei harbor a single elongated mitochondrion that runs from the posterior to the 
anterior of the cell.  In BSF parasites the mitochondria is a simple tubular structure containing no 
cristae, as the parasite relies solely on glycolysis for ATP production (Opperdoes and Borst, 
1977).  PF parasites, however, have an active mitochondrion with components of the Krebs cycle 
and the electron transport chain being present and active to facilitate ATP production (Besterio et 
al., 2002).      
 Located in the mitochondrion of the cell is an organelle known as the kinetoplast.  The 
kinetoplast is composed of the mitochondrial DNA (kDNA), arranged as a network of 
concatenated circles (Klingbeil et al., 2001).  The kDNA consists of thousands of minicircles 
(0.5-10kb) and only 40-50 maxicircles (20-40kb) that encode mitochondrial gene products such 
as rRNAs and respiratory chain subunits (Van Hellemond et al., 2005).  The expression of 
mitochondrial genes is unconventional, though, in that before the mRNA is competent to express 
a functional protein, it must be edited through the activity of minicircle encoded guide RNAs 
(Madison et al., 2002).   
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 The position of the kinetoplast changes as the cell moves through the various life cycle 
stages.  In BSF parasites, the kinetoplast is close to the posterior end of the cell whereas the 
kinetoplast is located midway between the cell nucleus and posterior end in PF parasites 
(Matthews, 2005).  The repositioning of the kinetoplast is the most obvious morphological 
difference between the different life cycle stages of the parasites.  The exact cellular mechanism 
of this repositioning is not clearly understood, but the correct positioning must occur for proper 
cell division in each life cycle (Matthews et al., 1995). 
Another unique aspect of trypanosome cell structure is the sequestration of select 
metabolic enzymes in small organelles called glycosomes (Opperdoes and Borst, 1977).  These 
organelles are abundant in the cell and share some similarity in content, structure, and 
biosynthesis to peroxisomes from other organisms (Parsons, 2004).  The proteins housed in these 
small membrane bound organelles vary throughout the life cycle of the parasite as nutrient 
availability changes (Michels et al., 2006). 
 
Glycosomes 
 Opperdoes and Borst (1977) first discovered glycosomes in T. brucei, revealing in BSF 
parasites these organelles housed nine glycolytic enzymes. The original discovery of these 
microbodies by Opperdoes et al. led to the name glycosome, to designate a unique organelle in 
the parasite (Parsons, 2004).  Similar to peroxisomes in other organisms, glycosomes are bound 
by a single phospholipid bilayer and contain no DNA.   Early studies revealed that the contents 
found in glycosomes were similar to those of peroxisomes in other organisms (Opperdoes, 
1984).   The hallmark peroxisomal enzyme found in other organisms is catalase, and only a few 
of the trypanosomatid species contain this enzyme in their glycosomes (Soares and De Souza, 
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1988).   Glycosomal matrix and membrane proteins are imported post-translationally by a family 
of proteins called peroxins (PEX) (Moyersoen et al., 2004).  Several peroxins have been 
identified in trypanosomes and are similar in sequence to yeast and human PEX proteins (Lorenz 
et al., 1998; Furuya et al., 2002; Guerra-Giraldez et al., 2002), .    
Biogenesis of glycosomes in T.  brucei is similar to the biogenesis of peroxisomes in 
other organisms (Moyersoen et al., 2004).   As the parasites encounter highly different 
environmental conditions in each life cycle stage, the contents of the glycosomes must change to 
adapt to metabolic needs.  When conditions change, as in the switch from the vector to the host, 
the contents in old glycosomes are no longer useful.  Therefore, these glycosomes are degraded 
and replaced.  This turnover process is a special form of autophagy, called pexophagy 
(Monastryska and Klionsky, 2006).   Pexophagy is an important process for the cell during 
differentiation from BSFs to short stumpy forms.   The process is more robust and rapid as the 
parasites transition from stumpy forms to PFs, reflective of a major change in environment 
(Herman et al., 2008).  This remodeling event ensures that the metabolic contents of the 
glycosome are most optimally suited for the current environmental conditions. 
Function of Glycosomes in BSF Parasites 
 Glycosomes of BSF parasites contain ~90% glycolytic enzymes, while the percentage of 
glycolytic enzymes in PF glycosomes is only 40-50% (Michels et al., 2006).  One main 
postulation for the compartmentalization of glycolytic enzymes in BSF is the inability of T. 
brucei hexokinase (HK) and phosphofructokinase (PFK) to be inhibited by their products 
(Nwagwa and Opperdoes 1982; Cronin and Tipton, 1985; Lopez et al., 2002).   Most HKs and 
PFKs, in other organisms, are tightly regulated by their products, or other metabolites, to prevent 
accumulation of glycolytic intermediates, which can be lethal to the cell (Haanstra et al., 2008).  
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Computer modeling to determine how glycolytic flux would be affected in BSF cells lacking 
compartmentalization of glycolytic enzymes revealed that steady-state glycolytic flux would not 
be altered, but that there would be a toxic accumulation of hexose-phosphates in the presence of 
glucose (Bakker et al., 1997).  The cell, therefore compartmentalizes the glycolytic enzymes to 
prevent this toxic accumulation (and coincident depletion of cellular ATP) and to control the 
enzyme activity of HK and PFK (Bakker et al., 2000).   The conclusion from this study and other 
studies reveal that glycosomes are essential for survival of BSF parasites (Guerra-Giraldez et al., 
2002; Furuya et al., 2002). 
The first seven enzymes of glycolysis are housed in BSF glycosomes to accomplish the 
conversion of glucose to 3-phosphoglycerate.  The remaining steps of the pathway are 
accomplished in the cytosol (Opperdoes and Borst, 1977).  Consumption and production of ATP 
and NADP by glycolysis are balanced within the glycosome and net ATP is produced in the 
cytosol of the cell, from the overall conversion of glucose to pyruvate (Opperdoes, 1987; 
Hammond et al, 1985; Hammond and Bowman, 1980). 
Not only are glyocomes essential for BSF survival, correct localization of enzymes to this 
compartment is vital.  Several studies have revealed that mislocalization of glycolytic enzymes is 
detrimental to the parasite (Blattner et al., 1998).  One glycolytic enzyme, phosphoglycerate 
kinase (PGK) has two major isozymes, one that is expressed in the BSF (PGKg) which localizes 
to the glycosome, and one that is mainly expressed in PF (PGKc) which resides in the cytosol.  
BSF parasites were rapidly killed when PGKg lacking a glycosomal targeting signal or PGKc 
were expressed.  These studies, among others, reveal that glycosomal compartmentalization of 




Function of Glycosomes in PF Parasites  
 PF parasites, unlike BSF, do not live in a glucose rich environment, but rather proline and 
threonine are the main carbon sources available in the insect vector.   The cells do, however, 
prefer glucose as their main carbon source if it is available (Lamour et al., 2005).  In vitro studies 
reveal that in glucose depleted media, PF parasites increase the rate (up to 6-fold) of proline 
consumption in the mitochondria for ATP production (Lamour et al., 2005).  
Growth rates of PF in glucose deplete media are not impacted by the absence of glucose.  
This observation led to the conclusion that glycolysis is not essential in PF parasites, and in turn 
compartmentalization of glycolytic enzymes is dispensable (Lamour et al., 2005).  In continued 
experiments, RNAi of PEX14, an essential protein for glycosome formation, was only lethal to 
PFs in the presence of glucose, which further confirmed that glycosomes are essential for PF 
survival only in the presence of glucose (Furuya et al., 2002).   
Unlike BSF glycosomes which house mostly glycolytic enzymes, glycosomes in PF 
parasites contain enzymes important in other metabolic pathways including the pentose-
phosphate pathway, purine salvage, β oxidation of fatty acids and biosynthetic pathways for 
pyrimidines, ether-lipids and squalenes (Michels et al., 2006). 
 
III.  GLYCOLYSIS IN T. BRUCEI 
 BSF parasites rely solely on glycolysis for ATP production, whereas, PF parasites utilize 
the breakdown of proline and threonine to generate ATP.  The glycolytic pathway, however, 
does play a role in PF biology, as RNAi of glycolytic enzymes triggers a change in surface 
molecule expression (Morris et al., 2002).  Also, rapid inhibition of glycolytic enzymes can be 
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lethal to PF parasites (Morris et al., 2002; Drew et al., 2003).  Therefore, glycolysis is an 
essential metabolic pathway in BSF and PF T. brucei. 
 
Hexokinase 
 Hexokinase (EC 2.7.1.1), the first enzyme in the glycolytic pathway, catalyzes the 
transfer of the γ phosphoryl group from ATP to glucose to yield glucose-6-phosphate and ADP.  
Although hexokinase is found in most living organisms, the enzyme is divergent across species 
with ~34% of the amino acid residues generally conserved in all members of the hexokinase 
family.  This strong conservation points to the biological relevance of these residues (Kuser et 
al., 2000).   Many organisms express more than one hexokinase and maintain pools of 
hexokinase containing several isoenzymes of different molecular mass and kinetic activity 
(Cardenas et al., 1998).   
 Sacchromyces cerevisiae expresses two hexokinase isoenzymes, PI and PII, which 
display 76% amino acid similarity (Kopetzki et al, 1985; Frohlich et al., 1985). The crystal 
structure of PII, similar to the structure of many other hexokinases, revealed that the molecule is 
distinctly folded into two domains: the large and small domains.  The two domains are separated 
by a deep cleft where the active site residues are found.  Many of the binding site residues in the 
cleft are strongly conserved across species (Kuser et al., 2000).    
 
Catalytic base of hexokinase 
The catalytic base of yeast HxkII has been identified as aspartic acid 211 (Asp 211) through 
tertiary structure determination and experimentation (Anderson et al, 1978.; Bennet and Steitz, 
1980). The residue promotes the nucleophilic attack of glucose’s 6-hydroxyl group on the γ-
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phosphate of ATP  followed by the transfer of γ-phosphate group to glucose (Jones et al., 1991). 
Asp 211 has also been determined to play an important role in glucose binding by hydrogen-
bonding to OH groups of the sugar.  Catalytic activity is lost when Asp 211 is substituted with 
another amino acid residue, however, high-affinity sugar binding is retained (Kraakman, et al., 
1999).  The catalytic aspartic acid residue is conserved in other hexokinases including human 
pancreatic β-cell glucokinase (Asp 205) (Charles et al., 1994; Gidh-Jain et al., 1993) and 
Trypanosoma brucei hexokinase 1 (Asp 214) (Morris et al., 2006) . 
 
T. brucei Hexokinase 1 and Hexokinase 2 
T. brucei expresses two hexokinases, TbHK1 and TbHK2, which are 98% identical at the 
amino acid level, with differences found in the C-terminal end of the proteins (Morris et al., 
2006).  TbHK1 and TbHK2 are arranged in tandem on chromosome 10, are both expressed in 
BSF and PF parasites (Berriman et al., 2005; Colasante et al., 2006).   RNAi and knockout 
experiments revealed that TbHK1 and TbHK2 are important for both life cycle stages of the 
parasite.  Both HKs are essential to BSF parasites, while PFs with a TbHK2 double allele 
knockout are viable, though distinct morphological characteristics were noted (Chambers et al., 
2008; Albert et al., 2005; Morris et al., 2006).  Current unpublished work suggests that TbHK2 
may play a role in glucose sensing in BSF as evidenced by its localization to the flagellum (Joice 
and Lyda, unpublished observation).  To date, PF TbHK1 double allele knockouts have not been 
successfully generated (M.Morris, unpublished observation).   The essentiality of the TbHKs in 
BSF parasites and their small percentage of similarity to human glucokinase (~30% similar), 
make them prime drug target candidates. 
 
 14 
A	  crystal	  structure	  has	  not	  been	  solved	  for	  either	  T.	  brucei	  hexokinase,	  however,	  
both	  proteins	  have	  been	  modeled	  on	  yeast	  PII	  (Morris	  et	  al.,	  2006).	  	  	  The	  modeling	  revealed	  
that	  the	  TbHKs,	  similar	  to	  yeast	  HKs,	  are	  composed	  of	  two	  domains	  separated	  by	  a	  deep	  
cleft	  containing	  the	  active	  site	  (See	  Figure	  1.3),	  and	  differences	  between	  the	  two	  almost	  
identical	  enzymes	  lie	  within	  the	  cleft.	  	  Several	  important	  active-­‐site	  residues	  are	  located	  in	  
this	  cleft	  along	  with	  the	  amino	  acids	  responsible	  for	  binding	  glucose	  (Morris	  et	  al.,	  2006).	  	  
Additionally,	  the	  catalytic	  base	  is	  located	  in	  the	  cleft	  (Kuser	  et	  al.,	  2000).	  	  Modeling	  also	  
revealed	  that	  the	  unique	  C-­‐terminal	  peptide	  sequence	  found	  in	  TbHK2	  may	  not	  allow	  for	  
conformational	  changes	  needed	  for	  catalytic	  activity,	  or	  may	  change	  the	  position	  of	  the	  
catalytic	  base	  and	  prevent	  activity	  (Morris	  et	  al.,	  2006). 
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Figure 1.3  T. brucei hexokinase modeled on yeast hexokinase II.   
DS-Modeler- generated structure of T. brucei hexokinase.  The protein is comprised of a large domain 
and small domain with a deep cleft containing catalytic residues between the two domains.  Catalytic 
residue, D214, is highlighted.   The N-terminal signal structures remain unstructured.  (Image adapted 
from: Morris, M. et al.  2006.  Activity of a Second Trypanosoma brucei hexokinase is controlled by an 
18-Amino-Acid C-Terminal Tail.  Eukaryotic Cell 5: 2014-2023.  Permission granted for use of figure.) 















Characterization of TbHKs 
Initial characterization of T. brucei hexokinase (TbHK) revealed that unlike most other 
eukaryotic HKs it is not regulated by Glucose-6-phosphate or ADP (Misset et al., 1986).  
Another early observation found that TbHK can use a myriad of substrates as its phosphoryl 
donor including ITP, UTP, CTP, GTP or ATP (Nwagwu and Opperdoes, 1982).   Early research 
also indicated instead of existing as a monomer or dimer in the cell, TbHKs exist as multimers, 
containing up to six subunits (Misset et al., 1986). 
Continued characterization of the enzymes revealed that the TbHKs localize to the 
glycosome, which is not suprising in that they both contain peroxisomal targeting sequences 
(PTS) at the N-terminal end of the protein.  Recent studies suggest that TbHK2 may also localize 
to the flagellum (Coley and Lyda, unpublished results).   Of note, rTbHK2 lacks detectable HK 
activity, while rTbHK1 does display hexokinase activity (Morris et al., 2006).  To this end, it is 
speculated that native HK activity is obtained from a mixture of TbHK1 and TbHK2 monomers 
because the molecular mass of the protein from which native HK activity was obtained was 
reflective of a hexameric oligomer (Morris et al., 2006).  The exact composition of the hexamer 
in its native state, however, is not currently known. 
 
Regulation of Hexokinase Activity 
As mentioned previously, TbHKs are unlike most eukaryotic hexokinases that are 
regulated via feedback inhibition by their products. Regulation of TbHKs is not accomplished in 
a conventional manner, but rather through non-conventional ways such as the oligomerization 
state of the enzyme or inhibition by fatty acids found in the glycosome (Chambers et al., 2008; 
Morris et al., 2006).   
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IV. GENE EXPRESSION 
 In order for a cell to survive under changing conditions, RNA is continually transcribed 
to carry on basic cell functions such as reproduction, growth, repair and regulation of 
metabolism.  Most organisms control gene expression at the level of transcription initiation.  
However, there are other control points that cells often employ to regulate transcription including 
RNA stability and transport, RNA processing and translation.  T. brucei regulate almost all gene 
expression post-transcriptionally, due to the polycistronic arrangment of the genome (Clayton, 
2002).    
 
Polycistronic Transcription 
 The genome of T. brucei is 26 Mb and consists of 11 chromosomes coding for ~9,000 
genes (Berriman et al., 2005).  The annotation of the T. brucei genome in 2005 confirmed that 
protein-coding genes are arranged in large polycistronic units, displaying a unique arrangement 
of gene structure for a eukaryotic parasite (Berriman et al., 2005).  Transcription, therefore, is 
accomplished in a polycistronic fashion with RNA Polymerase II transcribing up to several 
hundred contiguous genes (50-200kb) from one polycistron. Unlike operons in bacteria that 
encode functionally related genes, genes that are co-transcribed in T. brucei are not necessarily 
functionally related (Haile and Papadopoulou, 2007).    
The entire genome contains ~200 total bi-directional polycistronic units (Nilsson et al., 
2010).   Genes are transcribed in one direction (from the same strand) within a polycistronic unit; 
however, neighboring units can display convergent or divergent transcription (Siegel et al., 
2009). The region between two polycistronic units is called a strand switch region (SSR). In 
Leishmania major, a kinetoplast sharing 75% similarity in gene arrangement with T. brucei, the 
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SSRs have been shown to be initiation or termination sites for transcription with transcription 
starting between two divergent SSRs and terminating between convergent SSRs of polycistronic 
units (Martinez-Calvillo et al., 2003). It is thus hypothesized that T. brucei transcription start 
sites are also located at divergent SSRs (Siegel et al., 2009).   Further, recent data provides 
evidence that the chromatin structure at the SSRs plays a role in RNA polymerase II 
transcription initiation (Siegel et al., 2009).    
 
 
Figure 1.4  Diagram of Transcription/mRNA Maturation in T. brucei 
T. brucei genes are arranged in bi-directional polycistronic units with transcription of up to several 
hundred genes occurring from one unit.  Strand switch regions are located at divergent transcription sites.  
After transcription, the RNA is processed in a coupled trans-splicing/polyadenylation reaction to generate 
mature mRNA ready for translation.  (Figure	  adapted	  from:	  Haile,	  S.,	  and	  Papadopoulou,	  B..	  	  
Developmental	  regulation	  of	  gene	  expression	  in	  trypanosomatid	  parasitic	  protozoa.	  	  Current	  
Opinion	  in	  Microbiology.	  	  2007;	  10:	  1-­‐9.	  	  Permission	  granted	  for	  use	  of	  figure.) 
 
One other proposed mechanism involved in transcriptional initiation in kinetoplasts is the 
presence of a modified thymine, called Base J (Bernards et al., 1984).  This modified base was 
first discovered in the telomeric regions of expression sites of silenced VSGs in BSF parsites.   
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Base J is present in nuclear DNA specifically in inactive VSG expression sites.  For this reason, 
it was initially thought that Base J played a role in gene silencing, however, studies have 
revealed that this is most likely not the role of Base J (Cross et al., 2002).  Current data suggests 
that Base J is involved in some type of telomeric function, its exact role, though is yet to be 
discovered (Borst and Sabatini, 2008).  
The polycistronic nature of transcription implies that gene expression is not regulated at 
the level of transcription initiation in T. brucei , but instead is accomplished almost exclusively 
in a post-transcriptional manner.  To date only one RNA Polymerase II promoter has been 
identified and characterized from T. brucei.  This promoter is responsible for driving expression 
of the genes for the spliced leader (SL) precursor RNA.  Uncharacteristic of eukaryotic 
promoters, this promoter does not contain TATA or CCAAT boxes (Bayele, 2009). 
Other promoters have also been identified specifically for genes encoding the surface 
proteins of both procyclic form (PARP) and bloodstream form (VSG) parasites (Clayton et al., 
1990; Gottesdiener et al., 1991).  Notably, these genes are transcribed by RNA polymerase I, 
which is usually responsible for transcribing ribosomal RNA genes in other organisms.  With the 
exception of the few promoters identified, DNA sequences and proteins involved in initiation 
and termination of transcription are not well understood in T. brucei (Martinez-Calvillo et al., 
2010).   The lack of conventional RNA Polymerase II promoters and the mechanism of 
polycistronic transcription together suggest that transcription is primarily constitutive and gene 
levels are regulated following transcription.  Indeed, the experimental data acquired to date 
supports this claim, with elements in the 3’UTRs of genes playing a central role in regulation 




Processing of mRNA 
 mRNA processing of individual genes occurs after initial transcription of the long array 
of genes from each polycistronic unit.  mRNA processing in T. brucei is a coupled process 
entailing a 5’ and 3’ modification for the mRNA of each protein-coding gene.  The first 
processing reaction is a trans-splicing event in which a conserved 39nt SL sequence is added to 
the 5’ end of each protein-encoding RNA (Sutton and Boothroyd, 1986) providing a cap for the 
mRNA.  Bioinformatic tools have been used to predict splice sites, which are U-rich 
polypyrimidine tracts that precede AG acceptor sites (Clayton, 2002).  Recently, these sequences 
were confirmed experimentally in work published by Nilsson et al. (2010) in which high 
throughput sequencing was used to identify splice sites for almost all of the protein coding genes 
in T. brucei.  In these experiments, 2500 alternative splice sites were also identified.  The 
alternative splice sites identified are specific to one of the life cycle stages, revealing that 
alternative splicing may be a means of regulation for the parasite.   
Addition of the SL to the 5’ end of an mRNA is coupled to 3’ polyadenylation.  This is a 
coupled reaction, meaning the splice site for a particular gene influences the choice of the 
polyadenylation site for the gene directly upstream (LeBowitz et al., 1993).  Unlike higher 
eukaryotes, there is no conserved polyadenylation signal sequence in T. brucei, therefore 
prediction of polyadenylation sites can only be estimated by distance from the downstream 
trans-splicing event (Clayton, 2002).  In the past year, however, polyadenylation sites for almost 
6,000 T. brucei genes have been identified using RNA-seq technology (Siegel et al., 2010).  The 
data from this effort revealed that many genes contain several functional polyadenylation sites.  
The importance of multiple polyadenylated species for the same transcript has not yet been 




The changing environments that T. brucei encounters during its life requires plasticity in 
gene expression so that genes can be expressed at different levels as the environment and 
nutrient availability changes.  Most of the genes in trypanosomes are initially transcribed at the 
same levels from a polycistron (Martinez-Calvillo et al., 2010).  The coupled process of pre-
mRNA processing suggests that regulation does not occur during this event, as two unrelated 
genes that are located in tandem in a polycistron are processed in the same coupled reaction yet 
often exhibit distinct expression profiles (Kabani et al., 2009). Further, several genome wide 
studies have recently revealed that only a modest number (between 2-10%) of all T. brucei genes 
are regulated at the RNA level (Siegel et al., 2009; Brems et al., 2005; Koumandou et al., 2008; 
Jensen et al., 2009; Kabani et al., 2009). 
Post-transcriptional regulation can occur at several levels in the cell; mRNA stability and 
degradation, translational efficiency, and protein processing, modification and stability (Haile 
and Papadopoulou, 2007).  These post-transcriptional mechanisms of regulation can affect 
splicing, transport, stability, localization and translation of mRNAs (Ouellette and 
Papadopoulou, 2009).   There are many factors involved in controlling these regulatory processes 
including trans-factors such as RNA binding proteins and small RNAs (Clayton and Shapira, 
2007).  The trans-factors act on cis sequences usually found in the 3’UTRs of mRNAs (Ouellette 
and Papadopoulou, 2009).    
mRNA Stability and Regulation 
 One post-transcriptional mechanism through which trypanosomes regulate gene 
expression is RNA stability.  There are two different ways that mRNA degradation is 
accomplished in the cell.  An mRNA can be degraded through deadenylation by a poly A 
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nuclease followed by degradation in the 3’ à 5’ direction by the exosome (Buttner et al., 2006).   
An alternative route used in cells is the removal of the 5’ cap by a protein complex followed by 
mRNA degradation in the 5’ à 3’ direction (Parker and Song, 2004).  Trypanosomes express the 
proteins necessary for both deadenylation and decapping, and both activites have been detected 
in trypanosome lysates and deadenylation has been detected in vivo (Milone et al., 2002; Haile et 
al., 2003).  Sequences involved in stabililizing mRNA have been identified in the 3’UTRs of 
several trypanosome genes (Hehl et al., 1994).  Regulatory proteins or other trans elements that 
bind to the 3’UTRs to confer mRNA stabilization have not yet been identified (Clayton and 
Shapira, 2007). 
 
3’UTR Sequences Involved in Regulation 
 Sequences have been identified in the 3’UTRs of various T. brucei genes that regulate 
gene expression by controlling mRNA stability and degradation or by mediating translational 
efficiency (Clayton, 2002; Haile and Papadopoulou, 2007).  
The most efficient way to identify specific sequences of the 3’UTR involved in 
regulation is to use a reporter gene system.  After either stable or transient transfection of 
reporter gene constructs into pertinent cell lines, mRNA amount, protein expression and mRNA 
stability can be quantified (Clayton, 2007).   This technique has been used to identify regulatory 
regions in many T. brucei 3’UTRs. 
The EP procyclin 3’UTR is one of the most well characterized T. brucei UTRs.  Hehl et 
al. (1994) identified both a 16-mer and a 26-mer that are involved in regulating the expression of 
this protein.  The 16-mer enhances translation in PFs and the 26-mer is necessary for the 
instability of EP procyclin mRNAs in BSFs.  Though these are two of the most well 
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characterized sequences, many others involved in regulation of gene expression have been 
identified in trypanosome 3’UTRs.  In some genes, however, it has been challenging to narrow 
down specific regions and mechanisms involved in regulation (Clayton and Shapira, 2007).   
 
Coordinated gene expression 
Several recent publications examining genomic analysis during different life cycle stages of the 
parasite have revealed that post-transcriptional regulation is accomplished in a coordinated 
fashion (Kabani et al., 2009; Jensen et al., 2009; Queiroz et al., 2009).  These studies revealed 
clusters of coordinated gene expression, with many of the clusters containing genes with a 
variety of functions; however, some of the genes contained within the cluster were functionally 
related.  It is postulated that there may be proteins that recognize a group of mRNAs containing 
the same sequences in their 3’UTRs, conferring stability on the group of mRNAs in a 
coordinated way (Ouellete and Papadopoulou, 2009).  The set of mRNAs regulated together is 
referred to as a regulon.  The complete and detailed mechanisms of coordinated regulation and 
cellular components involved are not yet clearly understood.  Further characterization of the 
3’UTRs of the genes found in these regulons may reveal sequences that are involved in global 
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ABSTRACT 
Cellular responses to environmental changes include altered gene expression of metabolic 
genes.  In Trypanosoma brucei, regulatory elements in the 3’UTRs dictate transcript abundance 
and protein expression.  Through deep sequencing, multiple transcripts generated by differential 
polyadenylation have been identified for most genes.  Here, we have described how abundance 
and expression of seven different transcripts for T. brucei hexokinase 1 (TbHK1) are influenced 
by polyadenylation site in a carbon source-dependent fashion.  Under standard growth 
conditions, relative expression of the TbHK1 3’UTR lengths was similar in procyclic form and 
bloodstream form parasite, though overall expression was higher in the bloodstream form.  Of 
the seven tested, steady-state abundance of transcripts bearing one 3’UTR (1339 nt) was 
increased more than 9-fold in the presence of glucose, and two (1352 nt and 1086 nt) were 
reduced by more than 10-fold.  Translation for all lengths, as measured in a chloramphenicol 
acetyl transferase reporter assay, was either down-regulated or unchanged by glucose.  TbHK1 
expression was also dynamic as a result of growth in glycerol-based media, with the steady-state 
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levels of two transcripts (bearing either the 1331 nt or 1034 nt 3’UTR) increased more than 20-
fold while two (1352 nt and 1086 nt) were decreased more than 6-fold.  Translation from the 
transcript bearing the 1331 nt 3’UTR was also increased ~2-fold, while other 3’UTRs either had 
no impact or attenuated expression in response to glycerol.  Notably, steady-state transcript 
levels of the single polyadenylated TbHK2 species also responded to carbon source, with a ~3-
fold increase in the presence of glucose.  Translation of TbHK2 was nearly undetectable in the 
absence of glucose or glycerol, but similar was expressed at similar levels in the presence of 



















Organisms that occupy multiple biological niches must metabolically adapt to different 
environments.  Trypanosoma brucei, the protozoan parasite that is the causative agent of African 
sleeping sickness, alternates between a mammalian host and an insect vector.  As they move 
from the mammalian bloodstream to the tsetse gut and migrate to the salivary glands (through 
tissues and the hemocoel/plasma, a migration that is poorly understood), the parasites are 
exposed to a variety of environmental cues.  These include proteases and pH changes in the 
insect gut, fluctuating temperatures (the fly is a poikilotherm, so nighttime temperatures may be 
significantly less than day), and exposure to different small molecules, both as the bloodmeal is 
digested by the fly and during migration through fly tissues.   
For a small molecule to serve as an effective “marker” for a particular environment, its 
availability must change from one niche to another.  Glucose is an example of such a molecule.  
Short stumpy form parasites ingested by a feeding tsetse fly experience a rapid drop in glucose 
concentration, with the sugar in the blood nearly depleted in ~15 minutes (Vickerman, 1985).  
BSF parasites may also encounter changes in glucose concentrations.  Both cerebrospinal fluid 
and blood glucose concentrations increase in febrile children (Kirviranta et al., 1995) (fever is 
frequently associated with trypanosomiasis), while mice infected with T. rhodesiense have 
decreased serum glucose (Moon et al., 1968). 
In vitro, manipulation of glucose levels trigger changes in gene expression, supporting 
the hypothesis that the sugar may act as a key player in environmental sensing.  For example, 
GPEET procyclin expression is regulated by mitochondrial enzymes in response to changes in 
glucose concentrations in the culture (Vassella et al., 2004).  Cultured BSF can be triggered to 
express PF parasite characters by removal of glucose from the growth medium, even at 37oC 
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(Milne et al., 1998).  Last, RNAi silencing of glycolytic genes, including the TbHKs, disrupts the 
developmentally coordinated expression of surface molecules in PF parasites, suggesting a 
connection between the metabolic pathway and development (Morris et al., 2002). 
Because the trypanosome genome is organized with protein coding genes arrayed in units 
transcribed into single polycistronic RNAs, post-transcriptional mechanisms serve as key 
regulators of gene expression control.  Following transcription of the pre-mRNA polycistron, 
maturation of individual messages occurs in two coupled reactions, with trans-splicing adding a 
small capped RNA (the splice leader, SL) to the 5’ end while cleavage and polyadenylation 
provide the maturation of the 3’ end of the gene.  As a result of this maturation process, which is 
common for all protein coding genes, gene regulation is usually mediated by elements found in 
message 3’UTRs.  For example, the 3’UTRs of procyclins have been shown to regulate both 
mRNA levels and translation (Hotz et al., 1997).  Elements involved in post-transciptional 
regulation have been identified, including a glucose and glycerol response element in the 3’UTR 
of GPEET procyclin (Vassella et al., 2004).   
Hexokinase (HK), the first enzyme in glycolysis, catalyzes the phosphorylation of 
glucose to form glucose-6-phosphate.  T. brucei strain 927 harbors two TbHK genes, TbHK1 and 
2, that are encoded in tandem on chromosome 10  (Morris et al., 2002; 2006).  Both genes are 
expressed in BSF and PF parasites, yielding polypeptides that are 98% identical (Morris et al., 
2006; Colasante et al., 2006).  While the putative 5’UTRs and ORFs of the genes are 98.5% 
identical at the nucleotide level, the 3’UTRs are dissimilar.  One consequence of the differences 
in the 3’UTRs is that transcript maturation yields a different number of mature polyadenylated 
messages.  Seven different polyadenylated TbHK1 transcripts have been identified in a genome-
wide analysis of transcript splicing and polyadenylation, while only one transcript for TbHK2 has 
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been identified (Siegel et al., 2010).  The molecular mechanisms behind the generation of the 
different species of TbHK1 message are unknown; however, here we present evidence that the 
different transcript lengths are maintained at different abundance and have distinct expression 
patterns in response to environmental growth conditions.  These findings suggest that differential 
polyadenylation of mRNA in T. brucei serves as a mechanism for gene regulation in the African 
trypanosome. 
 
MATERIALS AND METHODS 
Trypanosome growth and transfection - Procyclic form T. brucei 29.13, a 427 strain that 
expresses T7 RNA polymerase and the tetracycline repressor, were grown and maintained in 
SDM79 (Brun and Shonenberger, 1979) supplemented with 15% fetal bovine serum under 
standard growth conditions (29°C, 5% CO2).  For experiments performed in low glucose or 
glycerol supplemented media, SDM80 (Lamour et al., 2005) was prepared with 9% heat-
inactivated dialyzed FBS and 1% heat-inactivated non-dialyzed FBS and, where noted, 10mM 
glycerol was added to the culture.  Transient transfections (1 x 108  cells, 10µg DNA) were 
performed in 0.4 cm gapped cuvettes using an ECM 830 Electroporator (Genetronics, Inc., San 
Diego, CA).  Briefly, cells were pelleted (800 x g, 10 min), washed, and then transferred to a 
cuvette with DNA and transfected (1700V, 100µs, 3 pulses, 200ms).  Immediately after 
transfections cells were resuspended in SDM79, SDM80 or SDM80 supplemented with glycerol 
for 24 hours prior to RNA isolation, CAT assay or TbHK assay.  (Please note that results of 
assays performed in SDM79 (6 mM glucose) yielded results that were essentially identical to 




Constructs - For all CAT reporter constructs, pGAPRONE (Furger et al., 1997) harboring a 
CAT reporter gene under the control of a procyclin promoter was used as the backbone for 
cloning of the respective TbHK 3’UTRs.  In short, primers containing a BamHI site in the 
forward primer and XbaI site in the reverse primer for cloning were designed to amplify the 
varying lengths of authentic TbHK1 UTRs.  The preexisting EP1 3’UTR in the parent 
pGAPRONE vector was removed by restriction enzyme digest and amplified UTRs were ligated 
in its place.  All constructs were confirmed by DNA sequencing. 
 
Quantitative Real Time PCR - Steady-state mRNA abundance of constructs bearing the 
authentic TbHK1 UTRs was assessed by qRT-PCR using primers specific to the CAT reporter 
gene (F CAT:  5’ GCGTGTTACGGTGAAAACCT 3’ and R CAT:  5’ ATCACA 
GACGGATGATGAA 3’) which yields a 219 bp  PCR product.  Actin was used as the reference 
gene for all qRT-PCR experiments (F Actin: 5’ GCCACGTATTTCCATCCATC 3’ and R Actin: 
5’ CCTGAGCTTCATCACCAACA 3’).  For qRT-PCR, a total of 5 x106  PF parasites were 
pelleted (800 x g, 10 min), washed in PBS and total RNA isolated (Aurum™ Total RNA Mini 
Kit, Bio-Rad, Hercules, CA) followed by DNase treatment on the purification column per the 
manufacturers instructions.  A one-step qRT-PCR kit (iScript One-Step RT-PCR Kit with SYBR 
Green, Bio-Rad, Hercules, CA) was used for cDNA synthesis and amplification.  qRT-PCR was 
performed on an iCycler iQ System (Bio-Rad, Hercules, CA) and resulting data was analyzed 
using the Pfaffl method (Pfaffl, 2001). 
 
CAT Reporter Gene Assays -  Chloramphenicol acetyl transferase (CAT) activity was assessed 
in lysates from transiently transfected cells in a 96 well plate format using a GENios 
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spectrophotometer (Tecan Group Ltd., Switzerland). Twenty-four hours post-transfection, cells 
were counted and hypotonically lysed.  Assays were performed in 250 µL total volume 
containing final concentrations of 100 µM Acetyl-CoA (MP Biomedicals, Solon, OH), 100 µM 
chloramphenicol (MP Biomedicals, Solon, OH) and 0.5 µM DTNB (G Biosciences, Maryland 
Heights, MO).  The assay scores the transfer of the acetyl group to one of the two hydroxyl 
groups on chloramphenicol.  During this transfer, a thiol is released from the acetyl-CoA which 
reacts with 5,5-dithio-bis 2-nitrobenzoic acid (DTNB) to release 2-nitro-5-mercaptobenzoic acid 
(TNB), which then is measured by absorbance at 405nm.  
 
Hexokinase Assays - To assess hexokinase activity from PF cells, lysate was prepared as 
described (Chambers et al., 2008).   Hexokinase activity was measured in triplicate using a 
previously described coupled reaction (Morris et al., 2002). 
  
RESULTS 
The genome of the African trypanosomes is organized into polycistronic units that are 
transcribed into long RNAs that, through RNA maturation, yield functional transcripts.   As a 
result of this unusual transcription mechanism, regulation of gene expression occurs primarily 
post-transcriptionally with 3’UTR sequences serving to regulate gene expression.  Recently, 
Siegel et al. (Siegel et al., 2010) identified polyadenylation sites for 5,948 T. brucei genes using 
high throughput RNA sequencing technology (Siegel et al., 2010).  TbHK1 had seven distinct 
polyadenylation sites resulting in 3’UTR lengths of 1026, 1034, 1086, 1166, 1331, 1339 and 
1352 nt (Fig. 2.1A).   TbHK2, however, had only one polyadenylation site, yielding a 3’UTR of 
353 nt.  The relative abundance of the UTR lengths in PF parasites cultured in standard media 
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(SDM 79) was also reported, with 1339 nt being the most abundant (33% of the total) while the 
1352 nt and 1166 nt species made up 17% (each) of the total.  The remaining four lengths 
accounted for the rest, with each having an abundance of 8% (Sigel, 2010).   
 




 (A) Schematic representation of TbHK1 depicting the location and abundance of polyadenylation sites for the gene 
(Siegel, 2010).  The thickness of the arrow corresponds to the percentage of the UTR transcript detected in PF cells 
maintained in glucose-rich media: 1026, 1034, 1086 and 1331 (8% each), 1166 and 1352 (17%) and 1339 (33%).  
Relative abundance of a reporter gene bearing the different TbHK1 3’UTRs in PF (B) and BSF (C).  Both cell lines 
were transiently transfected with a construct containing the respective UTR length downstream of the CAT reporter 
gene.  qRT-PCR was used to measure CAT transcript abundance with actin transcript as a reference (Pfaffl, 2001). 
 
TbHK1 transcript abundance in both PF and BSF parasites is dependent on polyadenylation 
site.  The presence of multiple polyadenylated TbHK1 transcript species, particularly in light of 
the single TbHK2 species, suggested that the distinct UTRs might have a role in the regulation of 
TbHK1.  To study the consequences of the different lengths of UTRs on steady state mRNA 
levels, PF and BSF parasites were transiently transfected with an expression vector containing a 
CAT reporter gene fused to the TbHK UTRs, followed by analysis of CAT transcript levels by 
qRT-PCR using primers to the CAT ORF (Fig. 2.1B and 2.1C).   
In both PF and BSF parasites, the shorter UTRs typically yielded the highest relative 
abundance (compared to the reference gene actin), with the distribution of the relative transcript 
levels being remarkably similar between the two life cycle stages.  However, there are notable 
exceptions to this trend.  Unlike the PF cells, which maintain nearly twice as much 1339 nt 
3’UTR transcript as the 8 nt shorter 1331 nt construct, BSF have higher steady-state levels of the 
1331 nt 3’UTR than the 1339 nt length.   
 
TbHK1 3’UTRs influence both transcript abundance and gene expression in response to glucose 
depletion - The diversity of 3’UTRs associated with the TbHK1 gene led us to consider the 
possibility that the process of message maturation, particularly polyadenylation, may be part of a 
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response to environmental cues.  Using qRT-PCR, the transcript levels of CAT harboring the 
TbHK1 3’UTRs were quantified in PF cells that were either maintained in glucose-rich media or 
were shifted to low glucose media after transfection of the reporter.  In response to glucose, 
steady state levels of 1339 nt 3’UTR reporter were increased more than nine-fold (Fig. 2.2A).  
Transcripts harboring other TbHK1 3’UTR lengths were less responsive to glucose, with the 
1166 nt 3’UTR and 1026 nt 3’UTR in particular demonstrating little change in abundance.  
Transcript levels for constructs bearing the 1352 nt and 1086 nt 3’UTR were reduced, with the 
former reduced ~10-fold while the latter was reduced to undetectable levels.  
To assess the consequences of the 3’UTRs on expression, CAT enzyme activity was 
monitored from cell lysate from transfectants.  In the absence of glucose, expression from all 
constructs was detected, ranging from 3.22-8.5 units of CAT activity (Fig. 2.2B).  However, 
culturing the transformed parasites in the presence of glucose had a marked impact on CAT 
expression.  Expression of CAT from constructs harboring the two longest 3’UTRs  (1352 and 
1339 nt) was undetectable, while expression from other constructs was unaffected by the 
presence or absence of glucose (1086 nt, for example). 
 
Glycerol as a carbon source alters TbHK1 transcript abundance and expression in a 3’UTR-
dependent fashion - Glucose and glycerol have been identified as glycolytic substrates that can 
influence gene expression in PF T. brucei.  Both compounds regulate GPEET procyclin 
expression, for example, through a single element in the 3’UTR (the GRE) (Vassella et al., 
2004).  To assess the impact of glycerol on TbHK1 expression and determine if particular 3’UTR 
lengths influence the response, both transcript steady state levels and expression were scored in 
transiently transfected parasites grown in glycerol using the CAT reporters described above.   
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While the over-all fold change in transcript abundance was greater after cells were shifted to 
glycerol containing media (as compared to those shifted to glucose (Fig. 2.2A)), there was a 
notable conservation of the pattern of transcript abundance.  For example, constructs bearing the 
1086 nt 3’UTR were once again reduced (as a result of growth in either glucose or glycerol), 
while 1034 nt 3’UTR had a greater fold-change in both glucose and glycerol than the 1026 nt 
3’UTR constructs (Fig. 2.3A).  This trend was true with one dramatic exception – constructs 
bearing the 1331 nt 3’UTR were increased more than 30-fold in response to glycerol, while the 
1339 nt 3’UTR constructs were unchanged (Fig. 2.3A).  This observation contrasts with the 
observed relative increase in the 1339 nt 3’UTR construct in response to glucose (Fig. 2.2A).   
For the majority of the 3’UTRs, CAT expression was modestly altered as a result of 
culturing in the presence of glycerol (Fig. 2.3A).  Expression from constructs bearing the 1026, 
1034, and 1086 nt UTRs was repressed (1.45-2.7-fold), while the near complete repression of 
1166 and 1339 nt 3’UTR-bearing constructs was similar to the loss of expression observed for 
the same constructs in response to glucose.  Conversely, the expression from the 1331 nt 3’UTR 
construct was increased nearly 2-fold, and the 1352 nt 3’UTR was minimally enhanced (1.2-
fold), though the maintenance of expression of the latter construct is in marked contrast to its 






Figure 2.2  Transcript and expression levels of CAT bearing the seven different TbHK1 3’UTR lengths in glucose-rich media.   
(A) Transcript levels measured from PF cells cultured in either glucose-rich or deplete media following transient transfection with constructs harboring the 
TbHK1 3’UTRs.  Fold change was determined using the Pfaffl method with comparisons made between cells cultured in low glucose versus high glucose.  A 
value equal to one indicates no change in transcript abundance.  (B) Expression changes as a result of 3’UTR length.  CAT enzyme activity was measured from 
lysates of transiently transfected PF cells cultured under glucose-rich or deplete media, with units determined by comparison to standard curve.  (Hatched bars- 




Figure 2.3   Growth in glycerol also alters steady state TbHK1 transcript and expression in a 3’UTR-dependent fashion.   
(A) Steady state transcript levels or (B) CAT activity from PF cells transiently transfected with reporter constructs followed by growth with (hatched bars) or 
without (solid bars) glycerol supplementation of SDM-80.    
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Impact of growth conditions on TbHK2 expression and activity – The single 353 nt 3’UTR found 
on the TbHK2 transcript also influenced steady state abundance and expression in a nutrient-
sensitive manner.  Growth in the presence of glucose, but not glycerol, yielded a 3.6-fold 
increase in steady state transcript abundance.  At the level of CAT expression, growth in either 
glucose or glycerol yielded similar expression levels, while growth in the absence of either 




Figure 2.4.  TbHK2 3’UTR yields differential expression for cells grown in the presence of 
glucose or glycerol.   
(A) Steady state transcript levels or (B) CAT activity from PF cells transiently transfected with a reporter 
construct harboring the TbHK2 3’UTR followed by growth in the presence of glucose or glycerol.  Steady 
state transcript levels are relative to transcript abundance in the absence of glucose or glycerol, with all 






TbHK enzyme activity is dependent on carbon source availability  - HK activity in the African 
trypanosome is the result of multiple layers of regulation that include mechanisms that regulate 
steady-state transcript abundance and expression. Other mechanisms, including post-translational 
modification and oligomerization with TbHK2 (Chambers et al., 2008), are likely involved in 
regulation of TbHK activity, leading us to consider the impact of carbon source availability on 
cellular HK activity.  Cells grown in media supplemented with glucose had the lowest TbHK 
activity per cell, while parasites grown in media lacking glucose or supplemented with glycerol 
had 2.3 and 3.3-fold higher TbHK activity, consistent with the general increase in CAT 
expression observed in cells grown under the two conditions (Fig. 2.4).   
 
 
Figure 2.5 Growth conditions alter TbHK activity from PF lysates.   
Trypanosomal lysates prepared by hypotonic lysis of cells grown in media containing the indicated carbon source 






Cellular mechanisms for responses to changes in nutrient availability are found in 
organisms as diverse as microbes and man.  They are responsible for a fundamental process and 
include transcriptional, post-transcriptional, translational, and post-translational mechanisms but 
are unified in their importance for ensuring continued satisfaction of metabolic needs as 
environmental conditions change.  Here, we have described how differential polyadenylation 
generates mRNA species that bear 3’UTRs that influence both steady-state transcript abundance 
and expression in response to environmental growth conditions.   
Polyadenylation is critical for generation of the 3’ ends of mRNAs in eukaryotes.  
Additionally, it provides a mechanism for influencing transcript maturation, particularly when 
intronic polyadenylation sites yield alternatively spliced message.  Such a mechanism allows 
mammalian cells to generate isoforms of a given protein, and bioinformatic analysis suggests 
that ~50% of human genes have multiple polyadenylation signals, with ~20% having at least one 
intronic polyadenylation site (Gong et al., 2010; Tian et al., 2007; Tian et al., 2005). 
While the TbHK1 gene lacks introns, a similar mechanism may be at work here.  This 
model is distinct from regulation of gene expression through control of pre-mRNA processing, 
which is not anticipated because the genes found in polycistrons in T. brucei are functionally 
unrelated and not organized into operon-like clusters (Berriman et al., 2005).  Instead, pre-
mRNA is matured as described, with the 5’ addition of the SL to the 3’ gene providing 
information for cleavage and polyadenylation of the 3’ end of the 5’ gene.  Regulation, however, 
does occur at the choice of 3’ cleavage sites in response to environmental cues.  In eukaryotes, 
mRNA polyadenylation typically prevents message degradation, but in some cases can promote 
it, leading us to speculate that steady-state transcript abundance could be a reflection of 
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preferential degradation of some forms of TbHK1 message – with maintenance of others – 
depending on the polyadenylation site (Table 1).  This model is transcription-independent, which 
is key in the T. brucei system (because of the polycistronic transcription).  Alternatively, (or 
additionally), maturation may not occur at all sites at equal frequency in response to 
environmental cues, leading to an increase in some species over others.  In either case, 
alternative polyadenylation would likely yield mRNAs that bear different regulatory elements 









  +Glc + Gly -Glc +Glc +Gly 
TbHK1 1026 + +++ +++ +++ + 
 1034 +++ ++++ +++ + +++ 
 1086 - + +++ +++ +++ 
 1166 + +++ +++ + - 
 1331 + ++++ +++ + +++ 
 1339 +++ + +++ - - 
 1352 - - +++ - ++++ 
TbHK2 353 +++ + - + + 
 
Table 2.1.  Summary of the impact of different TbHK UTR lengths on transcript  
 
abundance and CAT expression. 
 
In agreement with previously published work (Siegel et al., 2010), the 1339 nt 3’UTR- 
bearing TbHK1 transcript was the most abundant message in media supplemented with glucose 
(Fig. 2.2A).  Interestingly, protein expression was not detected from the same construct when 
cells were grown in the presence of glucose.  This observation suggests that the transcript is 
synthesized and maintained but either lacks a cofactor required for protein synthesis or binds an 
inhibitor of protein expression under glucose-replete conditions. The two 3’UTRs with lengths 
most similar to the 1339 nt 3’UTR (1331 nt and 1352 nt) were not maintained at the transcript 
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level, suggesting that the stabilizing sequence may be removed during maturation of the shorter 
transcript (1331 nt) or masked by the longer 1352 nt 3’UTR.   
 The interesting difference in response to environmental nutrients at both the transcript 
and expression levels of transcripts bearing the 1339 nt and 1331 nt 3’UTR suggests that 3’UTR 
variants are generated to yield transcripts bearing distinct response elements.  The eight 
nucleotides (aacacttt) that distinguish the 1339 nt 3’UTR from the 1331 nt species are indeed 
over-represented in the genome, suggesting a potential functional bias.  With an average 3’UTR 
length of 604 nt, one would expect the 8-mer to populate the 5948 genes almost 55 times, but the 
sequence is found 111 times in the 3’UTR.  This may reflect an artifact of a bias for A/T in the 
3’UTR, but the sequence is found in the 3’UTRs of all five glycerol kinase (GK) genes 
(Tb09.211.3540, Tb09.211.3550, Tb09.211.3560, Tb09.211.3570, and Tb09.211.3590), 
suggesting some regulatory function in response to glycerol.  The observation that the constructs 
bearing the 1339 nt 3’UTR are suppressed relative to the 1331 construct in the presence of 
glycerol suggests that the sequence is a negative regulator.  Its presence in the 3’UTRs of the GK 
genes may reflect a regulatory mechanism to prevent catastrophic consumption of ATP by the 
enzyme in the presence of glycerol.  
 The 8nt difference between the 1339 nt and 1331 nt 3’UTR length also shared some 
sequence homology with the previously identified translation enhancer 16-mer element found in 
procyclin 3’UTRs (Hehl, 1994).  Predictive m-fold structures particularly to the 3’ end of the two 
different UTR’s reveal that the 1339 nt 3’UTR contains a stem-loop structure at the end of the 
UTR, whereas the 1331 nt length does not form this structure (Figure 2.6).  Interestingly, the 16-
mer element identified in procyclin also forms a stem-loop structure and is not functional when 
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this RNA structure is lacking.  Further characterization of this sequence is needed to fully 








     
 
 
Figure 2.6.  m-fold Structure of 1331nt and 1339 nt TbHK1 3’UTRs. 
m-fold predicated structure of (A) 1331 nt  (B) 1339 TbHK1 3’UTR.  Homology shared with the procyclin 16-mer 







Overall, our study reveals that differential polyadenylation is not stochastic, but rather is 
involved in conferring regulation of gene expression of the glycolytic enzyme, TbHK1.  The 
high number of genes with multiple polyadenylation sites from two recent RNA-seq efforts 
(Siegel et al., 2010; Kolev et al., 2010) suggests that the parasite likely employs this mechanism 
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GLYCEROL-3-PHOSPHATE ALTERS TRYPANOSOMA BRUCEI HEXOKINASE 
ACTIVITY IN RESPONSE TO ENVIRONMENTAL CHANGE 
Heidi C. Dodson, Meredith T. Morris, and James C. Morris 






The African trypanosome, Trypanosoma brucei, compartmentalizes some metabolic 
enzymes within peroxisome-like organelles, glycosomes.  The amounts, activities, and types of 
glycosomal enzymes are modulated coincident with developmental and environmental changes.  
Pexophagy, fusion of glycosomes with acidic lysosomes, has been proposed to facilitate this 
glycosome remodeling.  In vitro, the recombinant glycosomal enzyme T. brucei hexokinase 1 
(rTbHK1) was inactivated under acidic conditions.  Glycerol-3-phosphate (Gly3P), which is 
produced in the glycosome by glycerol kinase, mitigated acid inactivation of rTbHK1 and 
parasite lysate-derived TbHK activity. Glycerol-2-phosphate likewise prevented inactivation, 
while glycerol did not.   
Gly3P influences rTbHK1 activity at pH 6.5 by preventing substrate and product 
inhibition by ATP and ADP, respectively.  Gly3P protects rTbHK1 from quercetin (QCN) 
inhibition at pH 7.4 partially and completely at pH 6.5.  However, Gly3P does not alter the 
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interaction of QCN with TbHK1, as the lone Trp (Trp177) was quenched under all conditions 
tested.  These findings suggest potential novel mechanisms for the regulation of TbHK1, 
particularly given the changes in cellular concentrations of Gly3P and the acidification of 























Regulation of metabolism is a central response to environmental changes that the parasitic 
protozoan Trypanosoma brucei encounters in its lifecycle.  Metabolic pathways are adapted for 
nutrients available in either the tsetse fly vector or mammalian host.  For example, procyclic 
form (PF) parasites residing in the tsetse fly metabolize both glucose and amino acids, while 
glycolysis is the sole ATP source for bloodstream form (BSF) trypanosomes.   
Trypanosomes compartmentalize parts of the glycolytic pathway in an organelle called 
the glycosome.  These organelles contain the first six or seven enzymes of glucose metabolism as 
well as enzymes involved in ether lipid biosynthesis and fatty acid oxidation.  In addition, two 
enzymes involved in glycerol metabolism, glycerol-3-phosphate dehydrogenase (G3PDH) and 
glycerol kinase (GK) are localized to this compartment (Opperdoes and Borst, 1977). 
In the glycosome, glucose is initially converted to fructose-1,6-bisphosphate (FBP), a 
process that requires the consumption of ATP by both the trypanosome hexokinase (TbHK) and 
phosphofructokinase (TbPFK).  These two enzymes are unusual in that they are insensitive to 
feedback inhibition by their products (Nwagwu and Opperdoes, 1982;  Cronin and Tipton, 1985, 
1987).  One result of compartmentalization is that ATP production and consumption within the 
glycosome is balanced, with net ATP only synthesized in the cytosol.  It has been suggested by 
modeling experiments that compartmentalization prevents the unproductive consumption of the 
net ATP (referred to as “turbo-explosion”) by either the TbHKs or TbPFK (Haanstra et al., 
2008).  RNA interference (RNAi) studies of genes essential to glycosome biosynthesis support 
this observation, as glucose is toxic to PF T. brucei lacking glycosomes, presumably as a result 
of inappropriate consumption of cytosolic ATP (Furuya et al., 2002), while RNAi of TbHK in 
the glycosome deficient cells is protective (Kessler and Parsons, 2005).   
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The “turbo-explosion” model suggests compartmentalization protects the cell from 
inappropriate kinase consumption of ATP.  Additional layers of TbHK regulation have recently 
been identified, including alteration of enzyme activity as a result of changes in the 
oligomerization state of the enzyme.  Trypanosomes express two 98% identical TbHKs (TbHK1 
and TbHK2) that have different biochemical properties, including distinct sensitivity to 
pyrophosphate.  Changes in oligomer composition can influence in vitro enzyme activity and 
sensitivity to pyrophosphate (Chambers et al., 2008).  As further evidence of TbHK regulation 
mechanisms, TbHK1 can be inhibited by fatty acids that are found within the glycosome (Morris 
et al., 2006).   
The glycosomal protein repertoire is altered in response to developmental and 
environmental changes.  For example, as the parasite transits from the short stumpy form (which 
is found in the mammalian blood and are preadapted for life in the tsetse fly vector), glycosomes 
fuse with lysosomes (Herman et al., 2008).  A process similar to pexophagy, which is the 
autophagy of peroxisomes in response to metabolic changes found in yeast, has been implicated 
in the turnover of glycosomal components.  Here we demonstrate that TbHK1, which is sensitive 
to pH as a result of substrate and product inhibition, is protected by glycerol-3-phosphate 
(Gly3P), a metabolite that accumulates under some growth conditions.  These observations 








MATERIALS AND METHODS 
Reagents - ATP and ADP were purchased from Calbiochem (San Diego, CA).  To confirm 
purity (reported by the manufacturer to be >95%), both compounds were resolved by HPLC 
(Waters, Milford, MA) using an isocratic buffering system (100 mM KH2PO4 , pH 6.5, 1.2% 
methanol) on a Symmetry C18 (5µm, 4.6 x 150 mm) column at a flow rate of 1.0  ml/min.  
Compounds were detected at 259 nm on a dual UV detector and analyzed by Breeze 3.2V 
software.  Antisera to T. brucei glycerol kinase (TbGK) (1:100,000), T. brucei hexokinase 
(TbHK, which detects both TbHK1 and TbHK2) (1:100,000), T. brucei triosephosphate 
isomerase (TbTIM) (1:3,500), and T. brucei enolase (TbENO) (1:10,000) were the generous gift 
of Dr. Paul Michels (Laboratory of Biochemistry, Université catholique de Louvain).  Antiserum 
to T. brucei PEX11 (TbPEX11) (1:4,000) was the gift of Dr. Christine Clayton (Center for 
Molecular Biology Heidelberg, University of Heidelberg).  Quercetin (3,3’,4’,5,7-
pentahydroxyflavone) was purchased from Spectrum Chemical Manufacturing Corporation 
(Gardena, CA). 
 
Cell Culture and Transformation - Both procyclic and bloodstream form (PF and BSF) 
Trypanosoma brucei brucei strain 427 (29-13 and 90-13, respectively) were used in the cellular 
studies.  PF parasites were grown in SDM 79 (Wirtz et al., 1999; Wang et al., 2000) to a density 
of 1x107 cells/ml, collected by centrifugation (10 min, 3000 x g), and stored at -20°C until use.  
To lyse cell pellets, the parasites were thawed, washed, and resuspended in ddH20 to a final 
concentration of 1x108 cells/ml.  Lysis buffer (0.1% Triton X-100, 50 mM TEA, pH 7.4, 1 mM 
PMSF, 20mg/mL leupeptin, 100mg/mL TLCK) was added to the mixture to minimize protein 
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degradation upon lysis.  BSF parasites were treated similarly, with cell pellets frozen initially at a 
concentration of 1x106 cells/ml. 
 
Recombinant Enzyme and Assay Conditions- For purification of rTbHK1, a previously described 
protocol (Morris et al., 2006) was modified to increase yield.  Briefly, a starter culture of E. coli 
M15(pREP) harboring  pQE30 (Qiagen, Valencia, CA) with TbHK1 cloned in frame of a 6-His 
tagging sequence was grown in ECPM1 (Wigelsworth et al., 2004).  The starter culture was used 
to inoculate a 5 L culture in a bioreactor (Biostat B, B. Braun Biotech International, Allentown, 
PA) at 37oC supplemented with O2.  The culture was induced with 0.8 mM IPTG when the 
culture reached an OD600 between 3-5, and allowed to grow for 16 hours without O2 
supplementation.  The cell pellet was collected by centrifugation (5000 x g, 20 min, 4oC) and 
resuspended in His buffer (50 mM NaPO4, pH 8.1, 5 mM glucose, 150 mM NaCl, 0.1% Tween).  
Cells were passed through a cell disruptor (Constant Cell Disruption Systems, Sanford, NC) for 
lysis.  After clearing the lysate by centrifugation, the supernatant was run on a 50 ml ProBind 
column (Invitrogen, Eugene, OR) at a rate of 5 ml/min on a FPLC (GE Lifesciences, Piscataway, 
NJ) with a step gradient of 5 to 250 mM imidazole in His buffer.   Fractions were screened using 
HK activity assays and Western blotting and those containing rTbHK1 were pooled and 
concentrated.  Further purification by ion-exchange chromatography was performed using a 
HiTrap SP HP column (GE Lifesciences, Piscataway, NJ) with a gradient elution.  At the end of 
the purification, the protein was determined to be ~99% pure based on SDS-PAGE.  
HK assays were performed as described in triplicate using a coupled reaction to measure 
enzyme activity (Morris et al., 2006; Misset and Opperdoes, 1984).  In short, the coupled assay 
uses glucose-6-phosphate dehydrogenase (G6PD) to convert glucose-6-phosphate (G6-P) 
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generated by HK to 6-phosphogluconate with coincident reduction of NADP to NADPH, which 
is monitored spectrophotometrically at 340 nm.  Reagent final concentrations in the 200 µl 
reactions were (unless otherwise noted):  50mM triethanolamine (TEA)/ 3-(N-morpholino) 
propanesulfonic acid (MOPS)/ piperazine-N,N’-bis (2-ethanesulfonic acid) (PIPES), 3.3mM 
MgCl2, 20mM glucose, 5.25mM ATP, 0.75 mM NADP, and 0.1 units of G6PDH.  For protection 
assays, Gly3P (20 mM) was added with the other assay components.  Kinetic analyses were 
performed using KaleidaGraph 4.1 (Synergy Software, Reading, PA) with the Michaelis-Menten 
curve fit algorithm.  
 
Enzyme activity in parasite lysates - PF or BSF parasites were lysed as described above.  Cell 
equivalents (1 x 105 or 4 x 105 for PF and BSF, respectively) were mixed with all HK assay 
components and the HK reaction monitored spectrophotometrically.  
 
Tryptophan Quenching Assay of TbHK1 –Quercetin (QCN) (varying concentrations) and Gly3P 
(20mM) were added individually and in combination to a solution (3 mL) of 0.1M MOPS, pH 
6.5.  A scanning spectrofluorometer (QM-Y, Photon Technology International, Birmingham, NJ) 
was used to monitor emission from 300-550 nm after excitation of the lone Trp on TbHK1 
(W177) at 280 nm (Dodson, 2010).  Once background emission was acquired, ~1 ug of TbHK1 
was added to the cuvette, mixed by pipetting and a second emission scan was performed.  Using 
Photon Technology International (PTI) software, the area under the emission curve from 370-
380nm was integrated.  The values were converted to Trp emission lost and plotted versus 





Starvation triggers altered abundance of some glycosome-resident proteins.  PF 
trypanosomes can adapt their metabolism to conditions of low glucose, presumably by up-
regulation of amino acid metabolism (ter Kuile, 1997; McCann et al., 2008).  Because of this 
dynamic metabolism, PF parasites can grow normally in the near absence of glucose.  Complete 
denial of nutrients by incubation in phosphate-buffered saline, however, has been shown 
previously to trigger association of glycosomes with the lysosomal compartment in PF cells, a 
process similar to pexophagy in yeast (Herman et al., 2008).  
 
Figure 3.1.  Incubation of PF parasites in PBS leads to altered abundance of glycosome-
resident proteins. 




cells, lane 1 and 2, respectively) 




cells, lane 3 and 4) were probed with antisera raised 
against glycosomal residents (TbGK, TbHK, TbTIM), a glycosomal membrane protein (TbPEX11) 
(Lorenz et al., 1998) and a cytosolic protein (TbENO).  
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To assess the consequence of association of glycosomes with acidic compartments, 
parasites were grown under standard conditions or incubated in PBS, a process known to trigger 
trypanosomal autophagy (Herman et al., 2008) and cell lysates probed with antisera to 
glycosomal resident proteins and cytosolic proteins.  Incubation in PBS led to a modest decrease 
in TbHK signal (likely a mixture of TbHK1 and TbHK2, as the antisera does not discriminate) 
(Figure 3.1, lanes 3 and 4).  TbGK abundance is not depleted, while TbTIM levels are markedly 
reduced.  The impact of incubation in PBS is not systemic, as the cytosolic-resident glycolytic 
enzyme TbENO and the glycosomal membrane protein TbPEX11 are not impacted.  These 
findings are similar to those reported in earlier studies on autophagy (pexophagy) of glycosomes 
that occurs after brief incubation of cells in PBS or during differentiation (Herman et al., 2008).  
TbHK1 is pH sensitive, but Gly3P prevents inactivation.  To explore the potential impact 
of fusion of the glycosome with the acidic (pH 4.8) lysosome (McCann et al., 2008) on a 
glycosome-resident protein in vitro, purified recombinant TbHK1 was assayed under different 
pH conditions.  The recombinant enzyme, normally assayed at pH 7.4, is sensitive to acidic 
conditions, with ~ 50% reduction in activity at pH 7.0 and nearly complete loss of activity at pH 
6.5 (Fig. 3.2A).   
 Glycosomes are dynamic organelles that are subject to changes in pH and enzyme and 
metabolite content, depending on both the environment in which the cell resides and the life 
cycle stage.  For example, PF parasites grown in amino acid-based media rapidly supplemented 
with glycerol quickly accumulate Gly3P from undetectable levels to ~ 15 mM within an hour 
(Haanstra et al., 2008).  This increase is attributed to the activity of the sole cellular glycerol 
kinase (GK), a glycosome-resident protein (Haanstra et al., 2008).  The dynamic nature of 
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glycosome contents led us to consider the impact of Gly3P on pH-mediated inactivation of 
TbHKs. 
 
Figure 3.2.  TbHK1 inhibition under acidic conditions can be prevented by inclusion of Gly3P in 
the assay.   
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(A) pH profile of TbHK1 (150 ng) activity in the presence (white) or absence (black) of Gly3P.  Three 
different Good’s Buffers with buffering capacity in the range of pH tested were used for the assay: 
MOPS, PIPES and TEA. (B) TbHK1 activity in MOPS buffer at pH 7.4 or 6.5 with or without Gly3P, 
Gly2P, or glycerol (Gly) (20 mM each).   
 
Performing TbHK1 assays under acidic conditions in the presence of Gly3P modulated 
pH inactivation of the enzyme (Fig. 3.2A).  At pH 6.5, more than 50% of the TbHK1 activity 
observed at pH 7.4 was maintained when Gly3P was included.  Notably, detectable enzyme 
activity was maintained at pH 4.0 (the lowest pH tested) in the presence of Gly3P (Figure 3.3).   
 
Figure 3.3  pH profile of rTbHK1 activity +/- Gly3P 
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Hexokinase assays were conducted in reaction mixture using 50 mM TEA buffer from pH 4.0 to 8.0 with 
ATP as a phosphoryl donor.   
The pH of the reaction mixture remained unchanged after Gly3P addition, ruling out the 
possibility of Gly3P buffering the reaction.  In parallel experiments lacking Gly3P, the enzyme 
was inhibited at pH 7.0 (Fig. 3.2A).  Gly2P also prevented inactivation while glycerol did not 
(Fig. 3.2B).  Gly3P has no impact on TbHK1 oligomerization (a previously characterized 
mechanism for regulation of activity (Chambers et al., 2008)) indicating that the maintenance of 
enzyme activity that we observed is not related to a change in the nature of the hexamer (Fig. 
3.4).  While Gly3P may be serving as a molecular crowding agent that abrogates the impact of 
pH or temperature, substituting glycerol or PEG did not prevent inactivation, suggesting that if 
the observed results were due to crowding, it was a specific response to glycerophosphate 
compounds. 
 
Figure 3.4.  Resolution of rTbHK1 oligomers at pH 7.4 with various metabolites present.  
 rTbHK1 was incubated for 30 minutes at pH 7.4 in the presence of glucose (Lanes 2, 9) glucose and ATP 
(Lanes 3, 10), glucose, ATP and Gly3P (Lane 4), glucose and Gly3P (Lanes 5, 11), ATP and Gly3P 
(Lanes 6,12) or Gly3P alone (Lane 7,13) prior to resolution on a 4% native gel (as described in Chambers 




To ensure that the protection of the recombinant enzyme was not an artifact of the 
coupled enzyme assay, G6PDH was incubated at pH 6.0 with G6-P as substrate, thereby 
foregoing the need for HK to produce G6-P from ATP and glucose.  G6PDH activity was 
unaffected by the acidic pH, readily converting G6-P to 6-phosphogluconate at the acidic pHs 
tested here, in the presence or absence of ATP and glucose (Fig. 3.5).  Therefore our 
observations are not a result of altering the G6PDH coupled enzyme activity. 
 
Figure 3.5.  G6PDH activity at pH 7.4 and pH 6.0 with or without Gly3P.  
 A reaction mix of G6PDH (0.1 units/reaction), glucose-6-phosphate (20mM), and NADP (0.75mM) 
buffered to pH 7.4 (left) or 6.0 (right) was supplemented with or without Gly3P (20mM) and G6PDH 
activity measured spectrophotometrically at 340 nm.   
 
Gly3P and Gly2P, but not glycerol, also maintained authentic TbHK activity from both 
procyclic form and bloodstream form cell lysate at low pH (Figs. 3.6A and 3.6B).  These 
findings again suggest that the glycerol moiety is not merely serving as a protective agent but 
rather that the phosphate is important in maintaining activity.   
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ATP and ADP are inhibitory under acidic conditions.  The observation that Gly3P or 
Gly2P altered rTbHK1 activity led us to consider whether the change in pH was somehow 
altering the interaction of the protein with other phosphoryl-bearing compounds, including the 
substrate ATP.  At pH 7.4, a broad range of ATP concentrations support TbHK1 activity with an 
inhibitory consequence on activity only at very low (0.1 mM) and very high (15 mM) 
concentrations.  At pH 6.5, however, the enzyme is more sensitive to the substrate, with optimal 
activity at  ~1 mM (Fig. 3.7A) and inhibition at higher concentrations.  The affinity for ATP does 
not change dramatically at pH 6.5 (apparent Km of 0.22 ± 0.17 mM, compared to 0.28 mM at pH 
7.4 (9)).  The addition of Gly3P only slightly increases the apparent affinity to 0.16 ± 0.07 mM at 
pH 6.5.  
Supplementing the low concentration of ATP (1 mM) needed to fuel the TbHK1 reaction 
at pH 6.5 with ADP inhibited the enzyme (Fig. 3.7B).  ADP is a mixed inhibitor of TbHK1 (Fig. 
3.7C), with an IC50 of 4.2 mM.  The impact of ADP on the assay at pH 7.4 was reduced, yielding 
an IC50 of ~ 10 mM.  Similar experiments using AMP in lieu of ADP did not inhibit the enzyme.  
Additionally, introduction of additional MgCl2 into the reaction did not reverse inhibition, 
indicating that the inhibition was not a result of the nucleotide depleting Mg2+ required for 






Figure 3.6.  Hexokinase Activity in Cell Lysate with various glycerol moieties. 
 BSF lysate (4 x 105 cell equivalents (A)) or PF lysate (1 x 105 cell equivalents, (B)) were assayed for HK 
activity at pH 7.4 (black) and pH 6.5 (white) with or without the addition of Gly3P, Gly2P or Gly (all at 





Figure 3.7.  Substrate and product inhibit TbHK1 under acidic conditions.   
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(A) TbHK1 (150 ng) activity was assayed under acidic conditions (pH 6.5) including ATP from 0-20 mM 
in the assay.  (B) TbHK1 activity assessed in the presence of 1 mM ATP (competent for activity) 
supplemented with ADP (0-20 mM) at pH 6.5.  (C) ADP is a mixed inhibitor of TbHK1 at pH 6.5.  
Assays, performed as described in the Materials and Methods, were plotted using KaleidaGraph 4.1 
(Synergy Software, Reading, PA) with the Michaelis-Menten curve fit algorithm.    
 
Quercetin inhibition, but not binding, is relieved by Gly3P at pH 6.5.  To further 
characterize the interaction of Gly3P with TbHK1, we employed a fluorescent probe, quercetin 
(QCN), which inhibits TbHK1 with an IC50 of 4.1 ± 0.8 µM at pH 7.4 (Dodson et al., 2010).  
Additionally, QCN quenches fluorescence from the lone Trp residue (Trp177) that lies near the 
enzyme hinge adjacent to the catalytic base, Asp214 (Dodson et al., 2010).  At a concentration of 
QCN near the IC50 (10 mM), Gly3P prevents inhibition at pH 7.4, but fails to prevent 
inactivation by higher QCN concentrations (Fig. 3.8A).  Notably, at pH 6.5, QCN inhibition is 
abolished in the presence of Gly3P.   
To explore the consequences of Gly3P on QCN binding, TbHK1 was incubated with 
increasing concentrations of QCN in the presence or absence of Gly3P and the consequences on 
Trp177 emission assessed.  Under standard conditions (pH 7.4), QCN quenched 50% of Trp177 
emission at 35 µM (Dodson et al., 2010).  At pH 6.5, emission was similarly quenched by QCN, 
independently of the presence of Gly3P (yielding 50% quenching at 43 and 50 µM QCN, with or 








Figure 3.8.  QCN inhibition is relieved in the presence of Gly3P at pH 6.5.   
 
 79 
(A) TbHK activity in the presence or absence of Gly3P with varying concentrations of QCN (10 or 100 
µM).  (Please note that at pH 6.5 in the absence of Gly3P, activity is not detected, hence the lined bar is 
not visible.) (B) Trp177 emission is quenched by QCN at pH 6.5 in the absence (left) or presence (right) 
of Gly3P.  Increasing concentrations of QCN were incubated with rTbHK1 in a 100 mM MOPS, pH 6.5 
solution.  Trp177 was excited at 280 nm followed by an emission scan from 300-550nm.  The percentage 
of Trp emission lost upon addition of QCN was calculated from the emission peak between 370-380 nm.  
 
DISCUSSION 
T. brucei alternates between a tsetse fly vector and mammalian host, utilizing changes in 
environmental nutrient availability as part of a complex pathway to regulate development.  These 
changes include activation of “cryptic” mitochondrion in the BSF to a metabolically active 
organelle in the PF parasite.  Additionally, glycosome contents are altered in a developmentally 
coordinated fashion.  For example, BSF parasites metabolize glucose to 3-phosphoglycerate  (3-
PGA) within the glycosome, followed by further processing in the cytosol to ultimately yield 
pyruvate.  PF parasites, however, process glucose to 1,3-bisphosphoglycerate in the glycosome, 
indicating that the parasite utilizes stage-specific differences in glycosomal content to regulate 
metabolic pathways. 
 Changes in glycosome content occur through glycosomal autophagy (Herman et al., 
2008).  During differentiation, glycosomes co-localize with lysosomes, which occurs particularly 
quickly (and involves a high percentage of glycosomes) during the transition from short-stumpy 
form parasites (the mammalian blood form pre-adapted for life in the insect) to PF parasites 
(Herman et al., 2008).  As an example of the impact of this process, the levels of the glycosome-
resident protein aldolase are reduced (compared to levels in BSF) in short stumpy forms, and 
then increased again in the PF form, only to slowly decrease thereafter.  This process resembles 
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pexophagy, the mechanism for peroxisome turn-over in methylotrophic yeast that occurs when 
nutritional conditions change (Farre and Subramani, 2004).   
Here we have found that a change in protein environment (a change in pH) impacts the 
response of TbHK1 to both substrate (ATP) and product (ADP), heretofore unrecognized as 
regulators of enzyme activity (Fig. 3.9).  Product inhibition by ADP is not competitive with 
substrate, indicating that a secondary nucleotide binding site has been exposed in response to the 
acidic conditions of the assay.  The change in protein structure is subtle, as the enzyme functions 
at reduced ATP concentrations.  Under the more acidic pH conditions, QCN quenches Trp177 
fluorescence, indicating that it interacts with the protein.  However, the flavonol fails to inhibit 
the enzyme, suggesting that the subtle change in structure has moved the QCN binding site 
sufficiently far from the active site to allow activity (Fig. 3.9). 
We expect total TbHK activity to differ between BSF and PF parasites as BSF parasites 
rely exclusively on glycolysis for ATP production.  Reflecting metabolic differences in the life 
stages, glycolytic proteins make up ~90% of the protein content in BSF glycosomes, while in PF 
glycosomes, only ~40-50% of the protein content is glycolytic proteins (Michels and Opperdoes, 
1991; Moyersoen et al., 2004; Michels et al., 2006 ).  Nevertheless, TbHKs are important to both 
life stages, as TbHK1 and TbHK2 have been shown to be essential to BSF parasites (Chambers, 
2008 and Albert, 2005), while TbHK2-/- PF parasites are viable but the knockout has a 
pleiotropic impact on the cells.  Viable TbHK1-/- PF cells have not yet been isolated despite 
repeated attempts under different growth conditions (M.T. Morris, unpublished observation), 
suggesting TbHK1 is also essential to PF cells.   
The importance of the interaction of Gly3P with TbHKs, and the subsequent regulation of 
enzyme activity, can be inferred from parasites that lack glycosomes due to genetic manipulation 
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of the PEX14 gene, which is involved in peroxisomal and glycosomal protein import.  As a result 
of the PEX14 deficiency, glycosome biogenesis is blocked, yielding parasites that grow normally 
in the absence of glucose.  However, addition of glucose to cultures of PEX14-deficient parasites 
is toxic (Furuya et al., 2002).  Glucose toxicity has been proposed to result from the lack of 
appropriate compartmentalization of TbHKs and PFK, leading to uncontrolled consumption of 
ATP (Furuya et al., 2002).  Interestingly, RNAi of TbGK was found to rescue the parasites from 
glucose sensitivity in the PEX14-deficient background (Haanstra et al., 2008).  This observation 
suggests that the absence of TbGK leads to a reduction in cellular Gly3P that therefore allows pH 
inactivation of TbHK activity.  Without sufficient Gly3P to maintain TbHK activity, the cell is 
protected from the lethal  “runaway” activity of the enzyme. 
 
FOOTNOTES 
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The abbreviations used are: BSF, bloodstream form; G6-P, glucose-6-phosphate; G6PDH, 
glucose-6-phosphate dehydrogenase; Gly3P, glycerol-3-phosphate; GK, glycerol kinase;  HK, 
hexokinase;  PF, procyclic form; rTbHK1, recombinant Trypanosoma brucei hexokinase 1;  




Figure 3.9.  Model illustrating the potential consequences of pH and Gly3P on TbHK1 activity.   
The active site catalytic base, Asp214, and the only Trp, Trp177, are indicated on TbHK1 modeled to the crystal structure of S. cerevisiae 
hexokinase PII (Kuser, 2000).   This model lacks the unstructured N-terminal peroxisomal targeting sequence (PTS2).   ATP/ADP binding at a 
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Hexokinases from the African trypanosome, Trypanosoma brucei, are attractive targets 
for the development of anti-parasitic drugs, in part because the parasite utilizes glycolysis 
exclusively for ATP production during the mammalian infection.  Here, we have 
demonstrated that the bioflavonoid quercetin (QCN), a known trypanocide, is a mixed 
inhibitor of Trypanosoma brucei hexokinase 1 (TbHK1) (IC50 = 4.1 ± 0.8 µM).  
Spectroscopic analysis of QCN binding to TbHK1, taking advantage of the intrinsically 
fluorescent single tryptophan (Trp177) in TbHK1, revealed that QCN quenches emission 
of Trp177, which is located near the hinge region of the enzyme.  ATP similarly 
quenched Trp177 emission, while glucose had no impact on fluorescence.   
Supporting the possibility that QCN toxicity is a consequence of inhibition of the 
essential hexokinase, in live parasites QCN fluorescence localizes to glycosomes, the 
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subcellular home of TbHK1.  Additionally, RNAi-mediated silencing of TbHK1 
expression expedited QCN induced death, while over-expressing TbHK1 protected 
trypanosomes from the compound.   In summary, these observations support the 






















Trypanosoma brucei is the causative agent of human African trypanosomiasis and 
nagana, a wasting disease, in livestock.  The World Health Organization classifies T. 
brucei as a re-emerging/uncontrollable human pathogen, partly due to a lack of a vaccine 
and suitable treatments for the disease.  Current therapeutics for human African 
trypanosomiasis (HAT) may have serious side effects, including blindness and death 
(Barrett et al., 2003). 
 T. brucei relies exclusively on glycolysis for ATP generation in the mammalian 
bloodstream.  Hexokinases (HK) catalyze the first step in glycolysis facilitating the 
transfer of the γ-phosphoryl group of ATP to the C6 of glucose.  The parasite expresses 
two HKs, TbHK1 and TbHK2, with proteomic studies revealing that both are found in 
the mammalian bloodstream (BSF) and insect (PF) forms of the parasites (Colasante, et 
al., 2006).  Both the proteins reside in an unusual organelle called the glycosome that 
houses the majority of the enzymes that participate in glycolysis. 
TbHK1 and TbHK2 are 98% identical at the amino acid level (Morris, et al., 
2006).  RNA interference (RNAi) has been used to demonstrate that both enzymes are  
essential to the BSF parasites, as silencing of either TbHK1 or TbHK2 results in the loss 
of HK activity and cell death (Albert et al., 2005; Chambers et al., 2008).  In addition to 
this genetic evidence validating TbHKs as potential therapeutic targets, we have found 
that chemicals that inhibit HKs from other systems also inhibit TbHKs and are toxic to 
the trypanosome.  For example, the anticancer drug lonidamine (LND), which functions 
in part by inhibiting human HK (Floridi and Lehninger, 1983; Paggi et al., 1988), inhibits 
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both recombinant TbHK1 and HKs from parasite lysate.  Additionally, LND is toxic to 
BSF and PF parasites (Chambers et al., 2008), likely as a result (at least in part) of 
inhibition of TbHKs.  Supporting this, parasites were partially protected from LND-
induced cell death by ectopic over-expression of TbHK1. 
 Quercetin (3,5,7,3’,4’ pentahydroxyflavone, QCN) is an abundant naturally 
occurring flavanol found in plants such as apples, onions, and capers.  QCN and related 
flavanols are of interest as potential anti-cancer therapies, because they inhibit the growth 
of several types of cancer cell lines (Molnar et al., 1981; Suolinna et al., 1975).  Potential 
in vivo QCN targets include a number of enzymes that are inhibited in vitro, ranging from 
the Src protein kinase (pp60v-src) to HKs (Graziani, 1977; Graziani, et al., 1983).   
Biophysically, QCN has several unusual fluorescence properties, including 
intramolecular excited-state proton transfer and dual fluorescence behavior that have 
been exploited in the use of flavanols as environmental probes (Guharay et al., 2001).  
Additionally, QCN binding to bovine serum albumin has been studied using these 
spectral properties (Sengupta and Sengupta, 2002).   
 Here, we have characterized the impact of QCN on recombinant TbHK1 and 
transgenic parasites.  Our work builds on the observation that QCN is toxic to 
trypanosomes (Mamani-Matsuda et al., 2004), revealing that TbHK1 may be a molecular 
target of the flavanoid.  We have found that over-expression of TbHK1 provides 
protection from QCN, while RNAi depletion of TbHKs expedites parasite death.  
Additional spectroscopic investigations taking advantage of the intrinsic fluorescence of 
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QCN suggest that QCN toxicity may be due in part to binding near the TbHK1 active 
site, causing enzyme inactivation. 
 
MATERIALS AND METHODS 
Reagents 
QCN (3,3’,4’,5,7-pentahydroxyflavone) was purchased from Spectrum Chemical 
Manufacturing Corporation (Gardena, CA).  
 
Assays of recombinant and lysate-derived TbHK 
Recombinant TbHK1 was expressed and purified as described previously (Morris et al., 
2006).  Parasite lysates were prepared by hypotonic lysis of 1 x 107 cells in the presence 
of 1 mM PMSF, 20 µg/ml leupeptin, and 100 µg/ml TLCK.  The mixture was added to 
lysis buffer (for a final concentration of 0.1 M triethanolamine (TEA) pH 7.4 and 0.1% 
Triton X-100) and lysates used in HK assays. 
HK assays were performed in triplicate using a coupled reaction.  Briefly, assays 
used glucose 6-phosphate dehydrogenase (1 unit/assay, EMD Biosciences, Inc, Sand 
Diego, CA) as a coupling enzyme to reduce NAD+ to NADH during the oxidation of 
glucose-6-P to 6-phosphogluconic acid (Morris, et al., 2006), a reaction that can be 
monitored spectrophotometrically.  Final conditions were 0.1M TEA, pH 7.9 containing 
1.0 mM ATP, 33 mM MgCl2, 20 mM glucose, and 0.75 mM NAD+. Assays were 
performed in 96-well microtiter plate format in a GENios spectrophotometer (Tecan 
Group Ltd., Switzerland).   
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Tryptophan Quenching Assay of TbHK1 
Glucose (20 mM), QCN (50 µM) and ATP (varying concentrations) were added 
individually and in combination to a solution (3 ml) of 0.1M TEA, pH 7.4.  A scanning 
spectrofluorometer (QM-Y, Photon Technology International, Birmingham, NJ) was used 
to monitor emission from 300-550 nm after excitation of the lone Trp on TbHK1 (W177) 
at 280 nm.  After acquiring background emission, TbHK1 (~1 µg) was added to the 
cuvette, mixed by inversion, and an emission scan performed.   Using the Photon 
Technology International software, the area under the emission curves from 370-380 nm 
was integrated. Values were converted into the percent of Trp emission lost and plotted 
versus concentration of substrate/inhibitor using KaliedaGraph software version 4.03.  
Sigmoidal curves were fit to the plots and IC50 values were determined for the 
substrate/inhibitor by setting y equal to 50 and solving for x using the sigmoidal equation. 
 
QCN Localization in T. brucei by Fluorescence Microscopy 
PF parasites (29-13, a 427 strain) were grown in SDM-79 with the T7 RNA polymerase 
and the tetracycline repressor constructs maintained by the addition of 15 µg/ml G418 
and 50 µg/ml hygromycin to the medium.  BSF parasites (cell line 90-13, a 427 strain) 
were grown in HMI-9 supplemented with 10% fetal bovine serum and 10% Serum Plus 
(Sigma-Aldrich, St. Louis, MO) with the T7 RNA polymerase and the tetracycline 
repressor constructs maintained by the addition of of 1.5 µg/ml G418 and 5 µg/ml 
hygromycin to the medium. 
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For microscopic examination of QCN localization, T. brucei were grown to 1 x 
107/ml (PF 29-13) or 1 x 106/ml (BSF 90-13), harvested (800 x g, 10 min), and washed 
twice in modified PBS (5 mM KCl, 8 mM NaCl, 1 mM MgSO4, 20 mM Na2HPO4, 2 mM 
NaH2PO4, 20 mM glucose).  QCN (100 µM) was then added to cells in the modified 
PBS.  After incubation (15 min, at growth conditions), cells were pelleted, washed twice, 
and applied to slides after the addition of VectaShield mounting medium with DAPI 
(Vector Laboratories, Inc., Burlingame, CA).  Images were captured by epifluorescence 
microscopy (Axiovert 200M, Carl Zeiss MicroImaging, Inc., Thornwood, NY). 
For glycosome labeling, the aldolase peroxisomal targeting sequence (PTS2) 
(Blattner et al., 1995) was introduced into a red fluorescent protein (mCherry) modified 
pXS (Marchetti et al., 2000) expression vector to yield an N-terminal fusion with the 
mCherry.  Briefly, FPTS2 (5’AGCTTATGAGTAAGCGTGTGGAGGTGCTTCT 
TACACAGCTTG 3’) and RPTS2 (5’CTAGCAAGCTGTGTAAGAAGCACCTCCAC 
ACGCTTACT CATA 3’) were annealed and the resulting product cloned into pXS.  PF 
parasites were then transiently transfected with 10µg of the pXSAldoPTSmCherry 
construct and cultured 24 hr prior to examination.  Live cells were visualized after 
resuspension in mounting medium (with DAPI) diluted 1:1 in PBS.   
For RNAi studies, PF parasites were transfected and stable transformants selected 
as described (Wang et al., 2000).  TbHK1 was targeted specifically using an RNAi 
construct that targeted the unique 3’UTR of the transcript.  Briefly, RNAi of TbHK1 was 
achieved using pZJM harboring a 341 bp fragment previously identified as a 3' 
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untranslated region sequence (Morris et al., 2002).  Parasite growth was monitored on a 
Becton-Dickinson FACScan flow cytometer. 
 For studies exploring the impact of over-expression of TbHK1 in PF cells, 
parental cells (PF 29-13) were transformed with linearized pLew111(2T7)GFPb (Motyka 
et al., 2006) harboring the TbHK1 gene in the multicloning site.  This vector fuses the 
green fluorescent protein (GFP) to the carboxyl termini of expressed proteins.  After 
selection for stable transformants, TbHK1 expression was induced by addition of 
tetracycline (1 µg/ml) to the media.  
 
RESULTS 
Glycolysis is essential to the parasitic protozoan T. brucei, suggesting that 
inhibitors of enzymes in the pathway may be suitable targets for therapeutic 
development.  TbHK1, which mediates the first step in this metabolic pathway, is an 
enzyme that has previously demonstrated to be essential for BSF parasites (Chambers et 
al. 2008a). As part of the validation of a high throughput screening campaign, we 
completed a pilot screen of a library of 1280 pharmaceutically active compounds 
(LOPAC, Sigma) (Sharlow et al, 2009.).  This screen yielded 12 primary hits including 
myricetin (IC50 of 48.9 ± 0.7 µM), a bioflavonoid that shares structural similarity with a 
known anti-trypanosomal compound, QCN (Fig. 4.1A) (Mamani-Matsuda et al., 2004).  
Further, the observation that QCN inhibited mammalian HKs (Graziani, 1977) suggested 
that the trypanosome TbHK1 could be a target of QCN.  These observations led us to 
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further explore QCN as an inhibitor of TbHK1 while considering the possible connection 
between TbHK1 inhibition and the reported anti-parasitic activity of QCN. 
 
QCN inhibits TbHK1 through mixed inhibition with ATP 
Incubation of recombinant TbHK1 with QCN followed by a coupled enzyme assay for 
HK activity revealed that the compound inhibited the enzyme (IC50 = 4.1 ± 0.8 µM) (Fig. 
4.1B).  Inhibition was not as a result of dissociation of TbHK1 oligomers (a previously 
characterized mechanism for regulation of activity (Chambers et al., 2008)), as QCN did 
not cause dissociation of TbHK hexamers.   
Many different kinases are inhibited by QCN, indicating that the molecule 
interacts with a structural feature common to all of the proteins, with the ATP binding 
site being a likely candidate binding site (Matter et al., 1992; Srivastava, 1985; Granot, 
2002).  Analysis of the nature of TbHK1 inhibition revealed that QCN was a mixed 












(A) Structures of myricetin and QCN.  IC50s for rTbHK1 are reported below the structure.  
(B) QCN inhibits rTbHK1.  Increasing amounts (0-100 µM) of QCN were incubated with 
rTbHK1 (160 ng/assay) for 10 min at RT and HK assays were performed as described in the 
Materials and Methods.  Please note that due to the complex nature of the mode of inhibition, IC50 
values were estimated assuming single site binding.  (C) QCN is a mixed inhibitor of TbHK1 
with respect to ATP.  Michaelis-Menten plots of inhibition with different QCN concentrations in 
assays containing varied ATP amounts.   
 
To determine if endogenous HK activity from parasite lysates was also sensitive 
to QCN inhibition, cell lysates from BSF or PF parasites were incubated with QCN and 
then assayed for HK activity.  QCN inhibited both BSF and PF HK activity similarly, 
with IC50s = 24 µM and 30 µM, respectively. 
 
TbHK1 inhibition coincides with changes in Trp177 fluorescence  
TbHK1 harbors a single Trp (residue 177) that is modeled to lie on the face of the 
enzyme near the hinge region and catalytic base (Asp214) (Fig. 4.2A) (Morris et al., 
2006).  Excitation of the single Trp177 in TbHK1 at 280 nm yielded a characteristic Trp 
emission band at ~370 nm (Fig. 4.2B, inset).  While QCN is intrinsically fluorescent with 
a maximum emission wavelength of 550 nm when excited at 280 nm, it alone yielded 
little fluorescence at 370 nm.  Addition of increasing amounts of QCN to TbHK1, 
however, quenched the Tryp177 emission, yielding an IC50 for quenching of ~ 35 µM 
(Fig. 4.2B).   
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 To further resolve the impact QCN was having on Trp177 emission, substrates of 
TbHK1 were included to determine their impact on fluorescence.  Addition of glucose 
(20 mM) alone did not alter Trp177 emission at 370 nm (not shown).  However, addition 
of ATP (0.05 mM) quenched the Trp177 emission ~20%, while additional ATP (to 5 
mM) nearly eliminated emission (Fig. 4.2C).  Addition of glucose with the ATP did not 










Fig. 4.2.  QCN bound to rTbHK1 alters Trp177 fluorescence.  
 (A) TbHK1 was modeled to the crystal structure of S. cerevisiae hexokinase PII (Kuser et al., 
2000).  The active site, Asp214, and Trp177 are indicated, along with residues that are involved 
in ATP binding in the C-terminal tail.  For clarity, the lower lobe of the protein has been isolated 
and rotated to position the C-terminal tail perpendicular to the page.  (B) Trp177 emission is 
inhibited by QCN.  TbHK1 (1 µg) was incubated with increasing concentrations of QCN in a 100 
mM TEA (pH 7.4) solution and, following excitation at 280 nm, emission monitored from 340-
500 nm.  To assess the percentage of Trp emission lost, the region between 370-380 nm (inset) 
was calculated and the % reduction in response to QCN determined.  (C) ATP and QCN quench 
Trp177.  Spectra were acquired from samples containing different amounts of ATP as described 
in 2B, and percentage of Trp emission lost calculated. Glucose (20 mM) was added as indicated. 
QCN localizes in part to glycosomes in live trypanosomes 
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Little is known about the mechanisms of action of QCN in the African trypanosome but 
the observation that the compound inhibits the essential TbHK1 led us to consider if the 
two shared subcellular localization.  To explore this, live PF parasites expressing 
glycosomally targeted mCherry were incubated with QCN and the fluorescence both 
scored by microscopy (Fig. 4.3A).  QCN accumulated in distinct foci, yielding punctate 
fluorescence that co-localized with the mCherry-bearing glycosomes.  Additional QCN 
fluorescence was observed as a light haze throughout the cell, suggesting that localization 
was not limited to glycosomes.  (Please note, parasite autofluorescence was not observed 
when similar exposure times were used on cells not incubated with QCN, suggesting the 
diffuse signal is due to the compound.)  Similarly, live BSF parasites yielded QCN 
fluorescence in punctate foci, a distribution suggesting subcellular localization, 
potentially glycosomal in nature (Fig4. 3A).  Additional staining was observed associated 
with the flagellum. 
The glycosomes, a peroxisome-like organelle, compartmentalizes the majority of 
the glycolytic enzymes in the trypanosome, many of which have been demonstrated 
genetically to be essential, including TbHK1 (Chambers et al., 2008).  The localization of 
a compound that inhibits TbHK1 in vitro to the compartment that houses the essential 
enzyme perhaps explains the cytotoxicity of the compound.  Previous research 
demonstrated that QCN is toxic to T. b. gambiense (LD50 = 10 µM) (Mamani-Matsuda et 
al., 2004). To confirm that our 427 T. b. brucei lab strain was also susceptible to QCN, 
parasites were incubated for 24 hr in the presence of compound and growth monitored by 
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cell counting.  QCN was found to be toxic to both BSF 90-13 and PF 29-13 
trypanosomes (LD50 = 7.5 µM and 35 µM, respectively). 
                          
Figure 4.3.  Localization and genetic manipulation studies to explore the biological 
consequences of QCN on T. brucei. 
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BSF and PF parasites incubated with QCN (100 µM, 15 and 10 min for PF and BSF, 
respectively) were stained with DAPI and imaged.  Glycosome localization in live PF cells was 
visualized by mCherry emission.  Fluorescence of the QCN does not bleed into the mCherry 
spectra and was captured using a 488 nm filter set.  Scale bar = 10 µm.  (B) RNAi of TbHK1 
enhances QCN toxicity, while over-expression of TbHK1 tempers it.  Parental PF trypanosomes 
(29-13) or parasites transformed with pLEW111(2T7):TbHK1 or pZJM:TbHK1 were induced 
with tetracycline (1 µg/ml) for 24 hours to either express or silence TbHK1, QCN (50 µM, 
dashed columns) added, and cell viability scored after an additional 24 hour incubation.  All 
assays were performed in triplicate, with cell numbers normalized to untreated controls.  The p-
values for untreated and treated parental 29-13 and pZJM:TbHK1 bearing cells were statistically 
significant (p < 0.05 in both cases), indicating that the differences between untreated and treated 
cells were significant, while the value for pLEW111(2T7):TbHK1 harboring cells incubated with 
or without QCN was not (p > 0.05) 
 
Exploring potential in vivo targets of QCN   
Unlike BSF parasites (which rely exclusively on glycolysis for ATP production), genetic 
manipulation of glycolytic enzymes, including over-expression and RNAi-based 
silencing, can be tolerated in PF parasites if the trypanosomes are first provided an 
opportunity to down-regulate hexose metabolism (Morris et al., 2002; Morris et al., 
2006).  If QCN is toxic as a result of its inhibition of glycolysis, increased cellular 
TbHK1 polypeptide could temper the toxicity of the compound.  To explore this, PF cells 
over-expressing TbHK1 from the inducible ectopic expression vector pLew111(2T7) 
were incubated with 50 µM QCN and cell growth compared to parental cell lines grown 
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under similar conditions (Fig. 4.3B).  After 24 hrs, cells over-expressing TbHK1 
displayed cellular HK activity 2.1 greater than control cells.  Additionally, these cells 
were more resistant to QCN with growth reduced only 10.1 ± 0.5% while growth of 
QCN-treated control parasites was repressed 55.5± 0.5%. 
The incomplete penetrance of RNAi (and the slowly developing phenotypes 
associated with the silencing) allows manipulation of TbHK1 abundance without 
detectable cell toxicity in PF parasites (Morris et al., 2002).  Therefore, we have explored 
the consequence of silencing TbHK1 on QCN sensitivity, with the prediction being that 
these cells may be more sensitive to the compound (that is, the remaining TbHK1 that 
results from incomplete penetrance will be inhibited more readily by QCN).   RNAi of 
TbHK1 using pZJM (TbHK1), which targets the distinct 3’UTR of TbHK1 (Morris et al., 
2002), was induced for 24 hours before cells were passed into medium containing QCN 
and cell growth compared to parental PF 29-13 parasites after an additional 24 hours.  
Silencing TbHK1 led to enhanced sensitivity to QCN, with cells induced to silence 




BSF T. brucei generate ATP exclusively by glycolysis, indicating that inhibitors of 
enzymes in the pathway may be therapeutic lead compounds.  The trypanosome 
glycolytic enzymes, TbHK1 and TbHK2, are potential drug targets.  These proteins, 
which are 30-33% identical to those from yeast, plants, and mammals, have a number of 
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unique biochemical features (in addition to amino acid composition) that suggest that 
identification of trypanosome-specific HK inhibitors may be possible.  These differences 
include mulitmerization of the enzyme into hexamers, localization of the protein to the 
glycosome, and sensitivity of the TbHKs to fatty acids (Chambers et al., 2008; Misset 
and Opperdoes, 1984; Morris et al., 2006).   
Genetic studies using RNAi have shown that both TbHKs are essential to the 
parasite (Albert et al., 2005; Chambers et al., 2008), and chemical inhibitors of the 
enzyme have demonstrated anti-parasitic activity in vitro (Chambers et al., 2008; Sharlow 
et al.; Willson et al., 2002).  Here, we report that QCN, a previously recognized anti-
trypanosomal flavanoid (Mamani-Matsuda et al., 2004), inhibits recombinant TbHK1.  
Amongst the mammalian enzymes that have been reported to be sensitive to QCN, 
including a tyrosine protein kinase, a phosphorylase kinase (Srivastava, 1985), a 
phosphatidyl 3-kinase (Matter et al., 1992), and a DNA topoisomerase (Boege et al., 
1996), the IC50s for QCN are similar to that of TbHK1, ranging from 3-300 µM.  This 
suggests that there may be limited increase in therapeutic range for the compound.  
However, the observation that QCN is not toxic to mammals at trypanocidal 
concentrations (Hu et al., 2001) supports the possibility that the partial localization of 
QCN to glycosomes (and the potential for concentration of the compound therein) may 
increase the therapeutic ratio favorably.  
Many of the other enzymes that have been reported to be sensitive to QCN share 
the feature of binding nucleotides or nucleotide triphosphates. It has been suggested that 
QCN inhibits Tyr kinases (like pp60v-src) by forming a hydrogen-bonded complex with 
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ATP, which would mimic the transition state of ATP and the tyrosyl residue of the 
enzyme (Granot, 2002).  A similar mechanism is unlikely in TbHK1, as QCN alone can 
quench Trp177 fluorescence. 
QCN has proven to be a potent anti-kinetoplastid agent, with toxicity toward 
Leishmania donavani  (Mittra et al., 2000) and T. brucei gambiense (Mamani-Matsuda et 
al., 2004).  In the former case, QCN inhibits DNA synthesis, leading to cell cycle arrest 
that triggers apoptosis.  Similarly, QCN causes T. brucei death through apoptosis 
(Mamani-Matsuda et al., 2004), though we propose the mechanism may be distinct.  In 
mammalian cells, mitochondrial associated HK activity is required to prevent apoptosis 
(Gottlob et al., 2001) and increased HK activity prevents oxidant-induced apoptosis 
(Bryson et al., 2002).  Our observation that QCN inhibits TbHK1 suggests that the 
apoptosis may be the result of a mechanism that measures HK activity, similar to that 
found in mammalian cells.  The TbHKs are unusual in a number of ways, including the 
finding that they oligomerize into hexamers (Chambers et al., 2008) and localize to the 
peroxisome-like glycosome (Misset and Opperdoes, 1984).  These characters suggest 
novel mechanisms connecting TbHK to cell signaling, which remain to be resolved. 
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ABSTRACT: 
Hexokinase activity is essential in Trypanosoma brucei and tightly regulated as small 
changes in expression level have dramatic consequences to cells.  T. brucei expresses two 
nearly identical hexokinases (TbHK1 and TbHK2) in both procyclic (PF) and 
bloodstream (BSF) form parasites. While the TbHKs share 98.5% identity at the 
nucleotide level from the 5’UTR through the ORF, the 3’UTRs are distinct, suggesting 
regulation of expression may be controlled by 3’UTR elements.  Using a deletion strategy 
to remove portions of the TbHK1 and TbHK2 3’UTRs, we have identified regions in the 
3’UTRs that are responsible for conferring regulation of expression.  Of note, the 3’UTRs 
of both genes contain putative K-box and CAAC elements.  In Drosophila, these 
elements bind microRNAs and function as negative expression regulators.  To determine 
if the putative K-box/CAAC elements are involved in differential regulation of 
expression of TbHKs, we assessed the impact of point mutations in the K-box of both the 
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TbHK1 and TbHK2 3’UTRs on reporter expression.  While a T to G point mutation in 
the TbHK1 K-box led to a 6-fold increase in expression, a similar change in the TbHK2 
3’UTR K-box had no effect.  Additionally, co-transfection of a synthetic anti-sense RNA, 
asRNA, (to mimic the possible K-box binding partner) restored TbHK1 expression levels 
suggesting that the K-box/CAAC motif may be an important element in regulating 




















T. brucei, the causative agent of African sleeping sickness, does not execute conventional 
eukaryotic mechanisms of transcription.  The protein coding regions of trypanosomatid 
genomes are organized into polycistrons containing up to several hundred unrelated 
genes (Haile and Papadopoulou, 2007).  Transcription is accomplished in a polycistronic 
fashion with every gene located on the polycistron being transcribed at the same time.  
The long precursor RNAs are then processed into mature mRNAs by a coupled trans-
splicing and polyadenylation reaction (Sutton and Boothroyd, 1986;  LeBowitz et al., 
1993).  The paucity of transcription factors and RNA polymerase II promoters in the 
genome and small percentage of differentially regulated genes noted in global gene 
expression profiling during development suggest that gene regulation is accomplished 
primarily post-transcriptionally (Clayton, 2002). 
 Post-transcriptional mechanisms of gene expression regulation in T. brucei 
include a number of cis-acting elements found in the 3’UTRs of the regulable mRNA 
(Clayton, 2002; Haile and Papadopoulou, 2007).  These elements generally influence the 
mRNA stability or translational efficiency of the transcript (Ouellette and Papadopoulou, 
2009).  Two of the most well characterized regulatory elements are found in the 3’UTR 
of procyclins, a U-rich 26-mer that confers mRNA stability and a16-mer that enhances 
translation in procyclic form parasites (Hehl et al., 1994). 
 Regulation via 3’UTR elements likely requires interaction with trans regulatory 
molecules that influence the stability or translation of the transcript.  For example, the 
Trypanosoma cruzi U-rich binding proteins bind to mucin mRNAs and regulate their 
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stage specific expression (D’Orso and Frasch, 2002).  In most other eukaryotes, small 
RNAs also serve as trans-regulators of gene expression.  These small RNAs include 
microRNAs (miRNA) and antisense RNAs (asRNA).  While computational efforts 
suggest that T. brucei may harbor a number of miRNAs, these have yet to be isolated 
(Mallick et al., 2008).  Similarly, asRNA has not been identified in T. brucei, though 
Leishmania expresses sense and anti-sense forms of non-coding RNAs (Dumas et al., 
2006).  The parasite does harbor the machinery to produce small RNAs, as demonstrated 
by a robust RNA interference response.  The role of this system, however, may be limited 
to one of genome protection from retrotransposable elements (Ullu et al., 2004).   
 T. brucei express two hexokinases, TbHK1 and TbHK2, in both the insect form 
and bloodstream form of the parasite (Colasante  et al., 2006).  TbHK1 and TbHK2 are 
located in tandem on chromosome 10 and encode proteins that are essential to the 
parasite (Morris et al., 2002; Morris et al., 2006; Berriman et al., 2005).  Little is known 
about the regulation of expression of these genes.  While the putative 5’UTRs and ORFs 
are 98.5% identical at the nucleotide level, the 3’UTRs are distinct, suggesting that 
regulatory information could be housed in the 3’UTRs.  Here we demonstrate the role of 
a metazoan-like microRNA-binding element in the regulation of TbHK1 expression, and 







MATERIALS AND METHODS 
Cell Culture and Transfections - PF parasites were grown in SDM-79 (Brun et al., 1979) 
and quantified prior to transfection.  A total of ~ 1.0 x 108 cells were transfected via 
electroporation (ECM 830 Electroporator, BTX, San Diego, CA) with 10 µg of plasmid 
DNA.  After electroporation, cells were cultured in SDM-79 (28°C, 5% CO2) and CAT 
assays were conducted after a 24 hour recovery period. Bloodstream form (BSF) 
parasites were grown in HMI-9 media (37°C with 5% CO2) and transfected.  After 
electroporation, BSF parasites were allowed to recover for 24 hours (37°C, 5% CO2) 
prior to lysing for assessment of CAT activity.  
 
Cloning of constructs for CAT Assays – Presumptive 3’UTRs were amplified by PCR 
from T. b. brucei genomic DNA and products cloned into pGEM (Promega, Madison, 
WI) and sequenced.  The TbHK1 3’UTR was amplified using F.TbHK1 3’UTR.BamHI 
(5’ GATCGGATCCGTGAGAAAACCATGCTTTTC 3’) and reverse primer R.TbHK1 
3’UTR.XbaI (5’ GATCTCTAGATATATATACCCTTTATTTGC 3’).  TbHK2 3’UTR 
was amplified with F.TbHK2 3’UTR.BamHI (5’ GATCGGATCCAGGTGA 
GTGTCCGCGAACG 3’) and R.TbHK2 3’UTR.XbaI (5’ GATCTCTAGATAACCG 
CTTGGATTCCTATTTTTC 3’).  The pGEM inserts were subsequently used to replace 
the EP1 procyclin 3’UTR in pGAPRONE (Furger et al., 1997).  This construct drives 
expression of the chloramphenicol acetyl transferase (CAT) gene from a procyclin 
promoter and was the generous gift of Drs. Erik Vassella and Isabel Roditi (University of 
Bern).  Deletion constructs were generated using a Phusion Site-Directed Mutagenesis 
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Kit (Finnzymes, Woburn, MA).  The K-box point mutants were created by site directed 
mutagenesis (QuikChange II Site Directed Mutagenesis kit, Stratagene, La Jolla, CA).  
 
CAT Assays - CAT activity was determined using a colorimetric assay with 5’-dithiobis-
(2 nitrobenzoic acid) (DTNB) as indicator.  In short, 24 hr after transient transfection, cell 
amounts were quantified, collected by centrifugation (3,000 rpm, 10’, RT) and lysed with 
water.   Acetyl-CoA (100µM final concentration/reaction) was added to an optically clear 
96 well plate with cell lysate followed by sequential addition of chloramphenicol (100µM 
final concentration) and DTNB (0.5 µM final). In brief, CAT activity is assessed using a 
colorimetric assay.  The assay measures CAT activity via the transfer of the acetyl group 
from acetyl-CoA to chloramphenicol.  This causes the which release of a thiol group t 
that then reacts with DTNB to release 2-nitro-5-mercaptobenzoic acid (TNB), which can 
be monitored spectrophotometrically at 405nm.   
 
mfold – mfold analyses were conducted using the mfold web server (version 3.2) in batch 
preparation (Matthews et al., 1999). Conditions were set to default (linear RNA, 37°C, 
1M NaCl, no divalent ions, 5% suboptimality, maximum interior bulge/loop size and 
asymmetry 30 nt, no limit on maximum distance between paired bases). The structure 
presenting the lowest initial dG was used for all subsequent analysis. 
 
RNA cloning and in vitro transcription - A synthetic anti-sense RNA (asRNA) was 
generated using primers F.TbHK1 3’UTR 1077.920RC.XhoI (5’ CACCTCGAGT 
CATTCATCTCCATTC 3’)  and R.TbHK1 3’UTR 1077.920RC.HindIII (5’ GTGAAGC 
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TTGAGGAGAGGAATCATA 3’)to amplify the reverse strand of the TbHK1 3’UTR 
from previously synthesized cDNA.  This product was subcloned into the pZJMα vector 
containing dual T7 promoters (Wang et al., 2000).  Following HindIII linearization of the 
vector, asRNA in vitro production was driven from the T7 promoters using an 
AmpliScribe T7 High Yield Transcription Kit (Epicentre Biotechnologies, Madison, WI). 
 
RESULTS 
Assessment of Basal Levels of Expression of TbHK1/2 
 To assess differential expression of TbHK1 and TbHK2 in BSF and PF parasites, 
a reporter gene system was employed to evaluate ratios of basal expression levels of these 
two almost identical proteins.  Putative sequences for both the TbHK1 3’UTR and 
TbHK2 3’UTR, 1297nt and 500nt, respectively, were cloned downstream of a CAT 
reporter gene.  Expression levels were quantified relative to TbHK1 3’UTR.  
Previously, analysis of steady-state mRNA levels suggested that TbHK1 
transcript was ~2-fold higher than TbHK2 (Morris et al., 2006).  In good agreement with 
this observation, the expression from the CAT/TbHK1 3’UTR construct was about twice 
that from the CAT/TbHK2 3’UTR construct in procyclic form parasites (Fig. 5.1).  It 
should be noted, however, that expression levels do not necessarily directly corelate with 
transcript levels, especially in an organism that regulates all gene expression post 
transcriptionally.  Differential expression was less robust in BSF parasites, with TbHK1 




Figure 5.1.  Differential expression of TbHK1 and TbHK2 in PF and BSF. 
CAT activity was assessed using putative full length CAT reporter constructs-TbHK1 
3’UTR (1077 nt) and TbHK2 3’UTR (500 nt) in PF (top) and BSF (bottom) parasites.   
 
Deletion Mapping of 3’UTR Regulatory Elements  
  Further, to identify putative regulatory elements involved in the expression of 
TbHK1 and TbHK2, deletion constructs were generated by removing portions from the 
proximal end or internal portion of each 3’UTR (Fig. 5.2).  Deletion of the proximal 300 
nt of the TbHK1 3’UTR ablated expression, suggesting that this region of the transcript 
harbors a positive regulatory region (Fig. 5.2A).  Additionally, removal of the proximal 
400 nt yielded expression levels less than full length, exposing a positive regulatory 
element located between 300-400 nt.  Removal of 600 nt from the UTR yielded ~1.5-fold 
higher expression.  These data together suggest a negative regulatory element located 
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between 300-600 nt of the UTR.  Overall, the deletions revealed that the TbHK1 3’UTR 
harbors several regulatory sequences to adequately regulate expression (Fig. 5.2A). 
Deletion analysis of the TbHK2 3’UTR suggested the presence of a negative 
regulatory element, though the mechanism is probably distinct from that of TbHK1 (Fig. 




Figure 5.2.  Mapping regulatory elements using truncation of the TbHK 3’UTRs fused to a CAT reporter.    
CAT reporter gene activity was assessed in constructs bearing deletions of either the TbHK1 3’UTR (A) or TbHK2 3’UTR (B-see next 










The 3’UTRs of TbHK1 and 2 harbor potential regulatory elements  
Deep sequencing of PF trypanosomes has revealed that the 3’UTR of TbHK1 
contains seven polyadenylation sites following the stop codon, while the 3’UTR of 
TbHK2 contains only one (Siegel et al., 2009).  The seven lengths of the TbHK1 UTRs 
range from 1026 nt to 1352 nt.    The core region of the UTR (the first 1026 nts) harbor 
proximal (nt 430-444) and distal (nt 992-1005) K-box (cTGTGATa) and CAAC motifs 
(Fig. 5.3A) (Lai et al., 1998). These elements mediate negative post-transcriptional 
regulation in Drosophila (and likely other metazoa) (Lai et al., 1998), and serve as a 
likely mircoRNA binding site (Lai, 2002).  In the TbHK1 3’UTR proximal K-box/CAAC 
motifs, the sequence and spacing between the K-box and CAAC elements is similar to 
that found in K-box/CAAC motifs from metazoans (Lai et al., 1998).  The distal set of 
motifs, however, lacks conservation of the sequence and spacing, with the CAAC motif 
5’ to the K-box.  RNA m-fold analysis (Matthews et al., 1999) of the TbHK1 3’UTR 
suggests that the K-box motifs are located on the same loop as their respective CAAC 
element (Fig. 5.3B).   
The 353 nt of the TbHK2 3’UTR contains a core K-box element (TGTGAT) at nts 
150-155 with a potential CAAC motif located 40 nts downstream (nt 196-199) (Fig. 
5.3B).  The TbHK2 3’UTR lacks the distal K-box/CAAC motifs.  RNA mfold analysis 
suggests that unlike the proximal K-box/CAAC motif in TbHK1, these sequences in the 




Figure 5.3.  Tandem arrangement of TbHK genes along chromosome 10 highlighting UTR features.   
(A)  The 5’UTRs (black) are defined by a region of high (>98%) conservation preceding the open-reading frames.  Hashed regions 
indicate ORFs with the highly variable 3’UTRs in white.  Putative K-box motifs are shaded in dark gray with nearby CAAC motifs in 
light gray.  Sequence data is given below each motif with conserved sequences underlined.  (B) M-Fold analysis of the predicted structures 







Mutating the TbHK1 K-box alters expression   
Deletion analysis suggested that the region of the TbHK1 3’UTR that harbors the 
K-box and CAAC motifs may play an important role in regulation of TbHK1 expression.  
To further assess this, a single nt change (T 431 to G) was made in the proximal K-box of 
the TbHK1 3’UTR.  This change led to a ~6-fold increase in CAT expression (Fig. 5.4A).  
A similar change in the TbHK2 3’UTR K-box (T 150 to G) had no impact on TbHK2 





Figure 5.4.  CAT enzyme reporter assays indicate that the proximal TbHK1 K-box 
is a negative post-transcriptional regulator. 
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 (A)	  Mutating	  the	  proximal	  TbHK1	  K-­‐box	  (top)	  results	  in	  ~six	  fold	  increase	  in	  CAT	  reporter	  
enzyme	  activity.	  	  Mutating	  the	  K-­‐box	  of	  TbHK2	  does	  not	  result	  in	  a	  change	  in	  CAT	  reporter	  
activity	  (compared	  to	  native	  TbHK2	  3’	  UTR	  sequence). (B) Co-transfection of TbHK1 3’ UTR 
asRNA 920.1077 with CAT reporter constructs. TbHK1 3’ UTR native and mutant K-box CAT 
reporter constructs were transfected or co-transfected with asRNA into PF parasites. Activity 
assays demonstrate minimal change for native TbHK1 3’ UTR co-transfected with asRNA; 
however, the large increase in expression observed for mutant proximal K-box TbHK1 3’ UTR 
CAT constructs is restored to approximately basal expression levels when asRNA is introduced. 
 
In an effort to further understand the mechanisms involved in the K-Box motif-
based regulation, we introduced the CAT/TbHK1 3’UTR constructs into an RNAi-
deficient background using a TbAgo-deficient cell line (the kind gift of Dr. E. Ullu, Yale 
University).  These results from these experiments were difficult to interpret, as 
regulation of all of the reporter constructs, including the EP13’UTR control construct, 
was unlike the parental control line PF29-13 (Fig. 5.5).   
 
Figure 5.5  CAT Expression Gene Assays in TbAgo-deficient cell line. 
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TbHK1 3’UTR (1297 nt) and TbHK2 (500 nt) and TbHK1 3’UTR K-box Mutant constructs were 
transiently transfected into Ago-/- cells.  CAT protein expression is reported relative to the 
TbHK1 3’UTR construct. 
 
Co-transfection of a synthetic asRNA rescues TbHK1 expression  
 In Drosophila, dme-mir2 and dme-mir11 family miRNAs have been identified that bind 
to K-box/CAAC motifs (Lai et al., 2004; Lai et al., 2005).  The curious presence of the 
distal CAAC/K-box, with the elements in a reversed orientation when compared to layout 
of the proximal elements, suggested that transcription of the distal element could yield 
RNA with partial complementary to the proximal K-box/CAAC motifs.  To explore this, 
we first generated in vitro a 157 nt RNA (nt 920-1077, asRNA) using sequence flanking 
the distal CAAC/K-box as template.  The asRNA was then co-transfected with CAT 
reporter constructs and the impact on expression assessed. 
 Co-transfection of the asRNA with the full length CAT/TbHK1 3’UTR had 
minimal impact on expression, indicating that the asRNA was not triggering an RNA 
interference based repression of expression (Fig.5.4B).  However, co-transfection with 
the reporter construct harboring the single nt change in the K-box (which led to a 3-fold 
increase in expression level) yielded a return to full length expression level.  The co-
transfection of the asRNA did not trigger changes in expression of unrelated genes, as 
CAT expression from a construct harboring the EP1 3’UTR was not altered by the 
presence of the asRNA.  Additionally, the asRNA had no impact on expression of the 
CAT/TbHK2 3’UTR construct. 
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A native anti-sense RNA (aRNA) corresponds to the distal K box of TbHK1  
While investigating the possibility that the K boxes of T. brucei are regulated by the same 
mechanism as the K boxes of other species (namely a non-coding RNA such as a 
miRNA), we probed for small RNAs which could contain a seed sequence 
complimentary to the K box. In doing so, we produced cDNA for a 157 nt transcript 
corresponding to the anti-sense strand of the TbHK1 3’ UTR at the 920th nt of the 3’ UTR 
and extending to nt 1077 (Fig. 5.6). Interestingly, the distal TbHK1 K box and CAAC 
motif are contained within this region on the sense strand, thus when a portion of this 




Figure 5.6.  An anti-sense RNA (aRNA) is produced in vivo from the non-coding 
strand of the TbHK1 3’ UTR.  
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The transcript detected by cDNA production includes at least the region from nt 920 to 1077 
which harbors the distal K box and CAAC motifs. This transcript is produced from a DNA strand 
from which canonical polycistronic transcription in this 5’ to 3’ direction has not been identified 




 Transcription in T. brucei is accomplished in a polycistronic fashion with many 
unrelated genes being transcribed from the same polycistron (Haile and Papadopoulou, 
2007).  Therefore, most all gene regulation occurs post-transcriptionally in the parasite 
with regulatory sequences controlling mRNA stability and translation often located in 
3’UTRs of genes.  The parasite must be able to confer regulation in a rapid manner due to 
the extremely different environments encountered during its life cycle. One of the most 
striking differences observed when comparing life cycle stages of T. brucei are the 
metabolic pathways utilized for ATP production.  This developmental difference involves 
the utilization of multiple metabolic pathways in procyclic form parasites to a sole 
dependence on glycolysis in bloodstream form parasites.  Genes involved in these 
metabolic pathways, then, must be tightly regulated according to environment and 
subsequent nutrient availability.  Here, we study mechanisms involved in regulating 
expression of the first enzyme in glycolysis, hexokinase. 
T. brucei expresses two hexokinases in both PF and BSF, TbHK1 and TbHK2, 
that are 98.5 % identical at the nucleotide level.  While the hexokinases exert little to no 
control over glycolytic flux (Albert et al., 2006), RNAi has demonstrated that both 
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TbHKs are essential (Morris et al., 2002; Albert et al., 2006) and transcript abundance of 
TbHK2 demonstrates a marked increase in BSF parasites over PF parasites (Siegel et al., 
2010) suggesting that life-cycle stage dependent expression of the hexokinases is 
regulated by the parasites. Further, our results indicate that study of TbHK post-
transcriptional regulation may yield fundamental insights into trypanosomatid biology.  
The different roles of the TbHKs in vitro (Chambers, Kearns et al., 2008; Chambers, 
Fowler et al., 2008; Chambers, Morris et al., 2008; Albert et al., 2006) are appreciated, 
however, the control of expression and functional significance of these differing roles has 
remained largely unknown. Herein, we have demonstrated that the TbHK 3’ UTRs can 
modulate differential expression of the two proteins in a stage dependent manner. 
We have identified approximate regions in both TbHK1 and TbHK2 that contain 
positive and negative regulatory elements controlling expression.  The identification of 
more than one regulatory element in the TbHK1 3’UTR suggests that regulation of this 
gene is complex and influenced by many different environmental triggers. 
 The observation that the 3’ UTRs of both TbHKs harbor at least one copy of a K 
box and associated CAAC motif identified in other species (Lai et al., 1998; Lai, 2002; 
Muttray et al., 2005) is of particular interest. In these species, families of 
developmentally regulated genes are often coordinately controlled by these post-
transcriptional regulatory elements (Fang and Qiu, 2009; Lai et al., 2005; Li et al., 2009). 
While we have not identified other members of a K-box regulated family in T. brucei, the 
stage dependent switch in metabolism and associated changes in protein expression 
profiles (especially of glycolytic enzymes) indicates a distinct possibility for such a 
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mechanism in the parasite. In addition, variability of K-box target sequence frequency as 
observed for the TbHKs occurs among other developmentally associated genes (Lai et al., 
1998) and could confer variable sensitivity or expression patterns.  
  In our subsequent analysis of the functional capacity of these K-box elements, the 
proximal K-box of TbHK1 was revealed to confer a strong negative post-transcriptional 
regulatory function. The sensitivity of this element to a single nucleotide substitution 
suggests a stringent sequence requirement in agreement with the high conservation 
observed in other species (Lai et al., 1998; Muttray et al., 2005; Wu et al., 2008). mfold 
analysis of our mutant K-box reveals no structural changes further implying a trans-
regulatory function. In contrast, the K-box of TbHK2 demonstrates little alteration of 
expression when similarly mutated. Under standard procyclic growth conditions, it 
appears as though the K-box of TbHK2 is either: 1) not a regulatory element, 2) not 
stringently adherent to sequence constraints, or 3) not actively involved in regulation. 
 In probing for elements which contain the seed sequence complimentary to the K-
box target as would be expected of a trans- regulatory ncRNA, we have identified the 
first instance of an RNA transcribed from the anti-sense strand of the 3’ UTR of a 
transcript for which it is capable of altering expression in trypanosomes. This is 
interesting as the transcript is produced from a DNA strand from which transcription was 
previously considered unlikely as such a mechanism would not conform to canonical, 
polycistronic transcription of the trypanosome genome. Whether this transcript represents 
a mature ncRNA or a precursor to some smaller RNA species (such as a miRNA) 
remains to be determined; however, the capacity to restore basal expression level when 
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co-ordinately introduced in super-cellular concentration with a mutant proximal TbHK1 
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Trypanosoma brucei, the causative agent of African sleeping sickness, expresses two 
hexokinases, TbHK1 and TbHK2, in both BSF and PF parasites (Colasante et al., 2006).  The 
current treatments available for sleeping sickness are toxic and difficult to administer in 
underdeveloped countries (Brun et al., 2010).   Hexokinase is considered a plausible drug target 
as glycolysis is the sole method used for ATP production in bloodstream form parasites.  Deeper 
understandings of the regulation of gene expression and regulation of enzyme activity for this 
essential protein could therefore have a great impact on development of an effective therapeutic.  
 
Regulation of Gene Expression 
 The study of gene expression regulation and how it occurs in T. brucei has long been a 
topic of interest due to the polycistronic organization of the genome, which results in a lack of 
transcriptional regulation (Haile and Papadopoulou, 2007).  It is important for TbHK1 to be 
regulated properly, as previous studies reveal that misregulation of the enzyme are harmful to the 
cell (Albert et al., 2005; Chambers et al., 2008).  
Through studying both the TbHK1 and TbHK2 3’UTRs and searching for elements 
involved in the regulation of gene expression, I have made several observations.  First, regulation 
of gene expression is complex and likely involves a myriad of both –cis and –trans regulatory 
elements in order for gene expression to be executed properly.  Initial studies to identify 
elements located in the hexokinase 3’UTRs involved in regulation revealed that there was no 
single element responsible for regulation, but instead this process involves several positive and 
negative elements that likely act in concert to regulate expression tightly.  The notable length of 
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the TbHK1 3’UTR (1352 nt compared to the average of 604 nt) also supports this possibility 
(Siegel et al., 2010). 
Second, the complexity of the regulation is likely closely linked to the unstable 
environmental conditions of the parasite.  The complexity may allow the trypanosome to quickly 
and efficiently adapt its gene expression to subtle (in the microenvironment) and gross 
environmental changes (for example, the switch from mammalian host to insect vector). In order 
for the parasite occupy diverse niches, they must first be able to sense environmental changes 
effectively, and then be able to respond rapidly in order to survive.  Previous studies to identify 
regulatory elements in the 3’UTRs of PF surface proteins reveal that nutrients play a role in 
regulating gene expression (Hehl et al., 1994).  Similarly, I have shown that the hexokinases also 
harbor elements in their 3’UTRs that respond to carbon source availability.  I have not yet 
identified the mechanism of this regulation and it likely entails regulation of both steady state 
transcript and protein translation levels.  However, it is clear that the parasite does change gene 
expression in response to carbon source availability.   
Lastly, my studies on differential polyadenylation reveal that some 3’UTR lengths are 
stabilized under certain environmental conditions; however, protein is not translated under those 
same environmental conditions.  Though logically it seems transcribing mRNAs that are not 
needed right away may not be the most efficient use of the cell resources, further thought reveals 
that it may be a mechanism that the parasite employs in preparation for rapid changes.  A recent 
review in Science by Keith Matthews states  “For such a rapid-response capability (switch from 
host to vector), a common strategy is to hold pre-made mRNAs ready for translation, rather than 
relying on new gene transcription and then protein synthesis (Matthews, 2011).” 
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Future efforts from this work include the identification of the elements that bind the 
3’UTRs, which may consist of nucleic acids and/or proteins.   Further work will also involve 
exploring the genome for other similarly regulated genes.  A high throughput analysis of whole 
genome expression of cells grown under different conditions could be utilized to identify such 
genes.  
 
Regulation of Hexokinase Activity 
Mechanisms of hexokinase activity are unique in T. brucei.   Unlike hexokinases in other 
organisms TbHKs are not inhibited by their products (Nwagwa, 1982; Cronin, 1985).  As 
aforementioned, the parasite must tightly regulate hexokinase gene expression subsequently, it 
must also regulate and maintain hexokinase activity under certain conditions.  Here I report that 
Gly3P is capable to regulate TbHK activity in an acidic environment.  The discovery of this 
means of regulation implies that the parasite utilizes small molecules that are readily available in 
the cell to maintain the catalytic activity of this important metabolic enzyme.  This regulatory 
mechanism may play an important role in the maintenance of stable metabolism as the parasite 
traverses through its life cycle.  Similar to rapid responses in gene regulation, enzyme activity 
must also remain tightly regulated to allow the parasite to effectively generate ATP as carbon 
source availability and cellular conditions change.   
 
Hexokinase as a Drug Target 
 Lastly, I have been involved on studies further confirming hexokinase as a viable drug 
target for the T. brucei.  As previously mentioned, current treatments available for 
trypanosomiasis are somewhat toxic and hard to administer. Hexokinase is considered a 
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plausible drug target because it is essential to BSF parasites and also due to its low similarity to 
human glucokinase.  I have been involved in characterization of quercetin, a previously 
recognized trypanocide, as a mixed inhibitor of TbHK1.  Through the study of quercetin a more 
clear understanding of hexokinase binding and enzyme conformation has been revelated.  
Currently, studies are underway in our lab and in collaboration with other labs to identify potent 
and effective inhibitors of hexokinase that could potentially be optimized and developed into a 
therapeutic.  Overall, the far reaching consequences and detriment of African sleeping sickness 
reveals the continued importance of studying the basic biology of the parasite to in turn be able 
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ABSTRACT
 The parasitic protozoan Trypanosoma brucei utilizes glycolysis exclusively for ATP production 
during infection of the mammalian host.  The first step in this metabolic pathway is mediated by 
hexokinase (TbHK), an enzyme essential to the parasite that transfers the γ-phospho of ATP to a 
hexose.  Here we describe the identification and confirmation of novel small molecule inhibitors 
of bacterially expressed TbHK1, one of two TbHKs expressed by T. brucei, using a high 




Methodology/Principal Findings:  Exploiting optimized high throughput screening assay 
procedures, we interrogated 220,233 unique compounds and identified 239 active compounds 
from which ten small molecules were further characterized.  Computation chemical cluster 
analyses indicated that six compounds were structurally related while the remaining four 
compounds were classified as unrelated or singletons.  All ten compounds were ~20-17,000-fold 
more potent than lonidamine, a previously identified TbHK1 inhibitor.  Seven compounds 
inhibited T. brucei blood stage form parasite growth (0.03 ≤ EC50 < 3 µM) with parasite 
specificity of the compounds being demonstrated using insect stage T. brucei parasites, 
Leishmania promastigotes, and mammalian cell lines.  Analysis of two structurally related 
compounds, ebselen and SID 17387000, revealed that both were mixed inhibitors of TbHK1 
with respect to ATP.  Additionally, both compounds inhibited parasite lysate-derived HK 
activity.  None of the compounds displayed structural similarity to known hexokinase inhibitors 
or human African trypanosomiasis therapeutics.  
 
Conclusions/Significance:  The novel chemotypes identified here could represent leads for future 











African sleeping sickness is a disease found in sub-Saharan African that is caused by the single-
celled parasite Trypanosoma brucei.  The drugs used widely now to treat infections are 50 years 
old and notable for their toxicity, emphasizing the need for development of new therapeutics.  In 
the search for potential drug targets, researchers typically focus on enzymes or proteins that are 
essential to the survival of the infectious agent while being distinct enough from the host to avoid 
accidental targeting of the host enzyme.  This work describes our research on one such 
trypanosome enzyme, hexokinase, which is a protein that the parasite requires to make energy.  
Here we describe the results of our search for inhibitors of the parasite enzyme.  By screening 
220,223 compounds for anti-hexokinase activity, we have identified new inhibitors of the 
parasite enzyme.  Some of these are toxic to trypanosomes while having no effect on mammalian 




African sleeping sickness conjures historical images of disease-induced fatal slumbering striking 
down men, women, and children, consequently decimating villages of colonial Africa.  
Unfortunately, people living in many countries of sub-Saharan Africa today know that African 
sleeping sickness is not a disease of history but rather is a much-neglected disease of the present, 
particularly in areas that suffer the additional burdens of war, famine, global and local climate 
changes, and other infectious agents.  The causative agents of sleeping sickness (or human 
African trypanosomiasis, HAT) are subspecies of the African trypanosome Trypanosoma brucei.  
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Approximately 500,000 people in sub-Saharan Africa are infected annually with the parasite 
leading to 50,000-70,000 deaths per year [1].  Similar to other neglected tropical diseases, 
limited therapeutics for HAT are available and of the drugs currently used, most have serious 
adverse side effects, including encephalopathy, toxicity, and death [2].  Thus, there is a desperate 
need for new HAT therapeutics with the preference shifting from general cytotoxic agents 
towards molecular target-based therapeutics that should display fewer toxic effects.  
Bloodstream form (BSF) T. brucei parasites generate ATP exclusively through glycolysis 
and T. brucei hexokinase TbHK, the first enzyme in glycolysis, has previously been validated as 
a target for therapeutic development.  In these experiments, BSF parasites were shown to be 
sensitive to RNA interference (RNAi)-based silencing of TbHKs [3,4], with cell toxicity 
observed after 3-5 days of RNAi exposure.  Additonally, known inhibitors of HKs have been 
demonstrated to inhibit T. brucei hexokinase 1 (TbHK1), one of two nearly identical TbHKs that 
the parasite expresses.  These compounds are furthermore toxic to the parasite [4].  While some 
mammalian HK inhibitors can inhibit TbHK1, TbHK1 is distinct enough from mammalian HKs 
to suggest that it can be specifically targeted.  Supporting this notion, TbHK1 shares only 30-
33% sequence identity with the mammalian HKs and differs further by unusual oligomerization 
into hexamers [5].  Moreover, the unusual spectrum of known inhibitors of the trypanosome 
enzymes, including fatty acids and other small molecules (like pyrophosphate, [5]), support the 
idea that this essential parasite protein is sufficiently distinct from any mammalian counterpart to 
make an ideal target for therapeutic development.  Indeed, targeting TbHK using structurally 
based inhibitors has yielded trypanocidal compounds, albeit at high concentrations [6,7].   
Here we describe our high throughput target-based approach to identify specific 
inhibitors of the essential parasite enzyme, TbHK1.  Overall, ten compounds were confirmed as 
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novel TbHK1 small molecule inhibitors exhibiting little or no similarity to known HK inhibitors 
(or HAT therapeutics).  Most of the potent TbHK1 inhibitors were toxic to culture-grown BSF T. 
brucei while not exhibiting toxicity towards mammalian cells, suggesting that they may be useful 
lead compounds in the development of new therapies for African trypanosomiasis.   
 
METHODS 
Chemicals and Reagents.  Clear 384-well microtiter plates were purchased from Greiner 
(Monroe, NC) and used for all experiments.  Glucose-6-phosphate dehydrogenase, β-
nicotinamide adenine dinucleotide (NAD+), adenosine triphosphate (ATP), lipoic acid (PubChem 
SID 11532893) and glucose were purchased from Sigma (St. Louis, MO).  Phosphoenol pyruvate 
(PEP), ebselen (PubChem SID 856002) and glucosamine were obtained through VWR (West 
Chester, PA) and dimethyl sulfoxide (DMSO) was purchased from Fisher (Pittsburgh, PA).  The 
following PubChem SID compounds were obtained from commercial vendors: 3716597, 
24830882, 17386310, and 16952891 (Enamine/Kiev, Ukraine); 24797131 (Chembridge/San 
Diego, CA); 14728414 and 17387000 (Specs/Delft, The Netherlands); 17507245 
(Asinex/Moscow, Russia); and 24785302 (ChemDiv, San Diego, CA). 
 
Compound Libraries.  The library of pharmacologically active compounds (LOPAC) (1,280 
compounds) was purchased from Sigma-Aldrich.  The Pittsburgh Molecular Libraries Screening 
Center (PMLSC) provided the 220,233 compound library screened for TbHK1 small molecule 
inhibitors, which was made available as part of the NIH Molecular Libraries Roadmap Initiative.  





Purification of Bacterially Expressed TbHK1.  For purification of bacterially expressed TbHK1 
(rTbHK1), a previously described protocol [8] was modified to increase yield.  Briefly, a starter 
culture of E. coli M15(pREP) harboring pQE30 (Qiagen, Valencia, CA) with the TbHK1 gene 
cloned in frame of a 6-His tagging sequence was grown in ECPM1 [9] and then inoculated into a 
5 L bioreactor (Biostat B, B. Braun Biotech International, Allentown, PA) and grown at 37oC.  
At OD600 between 3-5, the culture was induced with IPTG (0.8 mM), grown without supplement 
O2 (37oC, 16 hr), and cells collected by centrifugation (5000 x g, 20 min, 4oC).  The pellet was 
resuspended in lysis buffer (50 mM NaPO4, pH 8.1, 5 mM glucose, 150 mM NaCl, and 0.1% 
Tween) and lysed by using a cell disruptor (Constant Cell Disruption Systems, Sanford, NC).  
The resulting supernatant was applied (5 ml/min) to a 50 ml ProBind column (Invitrogen, 
Eugene, OR) on a FPLC (GE Lifesciences, Piscataway, NJ) and protein eluted by gradient (5 to 
250 mM imidazole) in lysis buffer.   Fractions were screened using HK activity assays and 
Western blotting and those containing rTbHK1 were pooled, concentrated, and applied to a 
HiTrap SP HP column (GE Lifesciences, Piscataway, NJ).   
 
Automated primary TbHK1 HTS and glucose-6-phosphate dehydrogenase coupled assays.  
TbHK1 assays were an adaptation of a coupled enzyme HK assay to a 384-well format [8,10].  
Briefly, test and control compounds (30 µM in 15 µL volume) were added to a 384 well black, 
opaque microtiter plate using a Velocity 11 V-prep (Santa Clara, CA) for a final test compound 
concentration of 10 µM.  Negative (vehicle) controls contained 1% DMSO, positive controls 
contained 133 mM glucosamine and IC50 controls contained 1.3 mM glucosamine (final well 
concentrations).   A mixture containing glucose (1.5 mM), ATP (1.05 mM), MgCl2 (4.5 mM), 
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NAD+ (9 mM), glucose-6-phosphate dehydrogenase (G6PDH, 0.018 mUnits/µL) and 
triethanolamine (TEA, 100 mM, pH 8.0) in a 15 µL volume was then added to each well of the 
assay plate using a Perkin Elmer FlexDrop (Waltham, MA) followed by addition of rTbHK1 (1.5 
ng/µl in 15µL volume).  The 45 µL reaction mixture was incubated at RT for 2 hr and then 
quenched with 5 µL EDTA (500 mM).  The resulting signal, which remained stable for up to 5 
hr after addition of stop reagent, was collected on a Molecular Devices SpectraMax M5 
(absorbance at OD340)(Sunnyvale, CA). 
 To account for possible inhibition of the reporter enzyme in the primary coupled reaction, 
putative inhibitors were screened to assess their activity against a G6PDH coupled assay.  
Briefly, test and controls compounds were added to the wells of a 384 well assay plates as 
described above. Negative (vehicle) controls contained 1% DMSO, positive controls contained 
100 mM PEP and IC50 controls contained 8.6 mM PEP (final well concentrations).  A mixture 
containing glucose-6-phosphate (G6P, 0.6 mM) and NAD+ (1.8 mM) in a volume of 15 µL was 
then added to each assay plate well.  The reaction was initiated by addition of 15 µL G6PDH 
(0.018 mUnits/mL) (for a final volume of 45 µl), incubated at RT for 1 hr, and then quenched 
with 5 µl of EDTA (500 mM).  The change in absorbance at OD340 was monitored as above.   
Additional specificity assays were performed using human HK 4 (human glucokinase, 
hGlk, GenBank accession no. BC001890) that was expressed from a cloned cDNA (OPEN 
Biosystems, Huntsville, AL) in pQE30.  After sequencing, the plasmid was transformed into E. 
coli M15 (pREP) and cultures were grown to an OD600 of 0.9 in terrific broth and protein 
expression induced (3 hr, 37°C) with 1 mM IPTG followed by purification by nickel-affinity 




Inhibition assays of lysate-derived TbHK.  Parasite lysates from BSF parasites were prepared by 
incubation (5 min on ice) of 1.5 x 107 cells in lysis buffer (0.1 M TEA, pH 7.4, and 0.1% Triton 
X-100) supplemented with 1 mM PMSF, 5 µg/ml leupeptin, and 100 µg/ml TLCK.   In triplicate, 
cell equivalents (2 x 105) were incubated with increasing concentrations of inhibitor for 15 
minutes at RT prior to initiation of the coupled reaction.  In short, the 200 µl reactions included 
50 mM TEA, pH 7.4, 33 mM MgCl2, 20 mM glucose, 5.25 mM ATP, 0.75 mM NADP, and 0.1 
units of G6PDH, with kinetic analyses performed using KaleidaGraph 4.1 (Synergy Software, 
Reading, PA). 
 
T. brucei viability assay.  To determine the impact of TbHK1 inhibitors on cell growth, we 
seeded 5 x 103 BSF parasites (cell line 90-13, a 427 strain) into 96-well clear-bottomed 
polystyrene plates in 200 µl HMI-9 supplemented with 10% fetal bovine serum and 10% Serum 
Plus (Sigma-Aldrich, St. Louis, MO) and grown in the presence of compound (2 µl) or 
equivalently diluted carrier for 3 days in 5% CO2 at 37oC.  CellTiter Blue (Promega, Madison 
WI) was added (20 µl) and the plates incubated an additional 3 hr under standard culture 
conditions.  Fluorescence emission at 585 nm was then measured after excitation at 546 nm in a 
GENios microtiter plate reader (Phenix Research Products, Hayward CA).  DMSO solvent was 
maintained at or below 1%, with 1% causing a 16% reduction in cell number at the end of the 
three day assay.   
Procyclic form (PF) parasites (29-13, a 427 strain, 5 x 104/well) were grown in 96-well 
clear-bottomed polystyrene plates in 200 µl SDM-79 for 2 days (5% CO2, 25oC) and then 
CellTiter Blue (20 µl) added.  Plates were then incubated for 1 hr under standard culture 




Mammalian cell-line and Leishmania promastigote specificity assays.  Cell-based specificity 
assays were performed as previously described [11].  Briefly, mammalian cell line and 
Leishmania promastigote assays were performed in final volumes of 25 µL using our previously 
described 384-well microtiter format [12].  All mammalian cell lines were cultured and 
maintained in complete growth medium preparations according to ATCC specifications (ATCC, 
Manassas, VA).   Leishmania promastigotes were cultured as previously described [11].  A549 
(1,000 cells/22 µL), IMR-90 (1,000 cells/22 µL), HeLa (1,000 cells/22 µL), MDA-MB-231 
(3,000 cells/22 µL), Leishmania promastigotes (5,000 parasites/22 µL) were seeded into each 
well of 384-well microtiter plates and test and control compounds (3 µl) were added to 
individual wells.  Vehicle and positive controls were 1% and 10% DMSO, respectively.  For 
mammalian cells, assay plates were incubated for 44-46 h at 37oC in the presence of 5% CO2 and 
for the Leishmania promastigotes, assay plates were incubated for 44 h at 28oC with 5% CO2.  
Five µL of CellTiter Blue reagent was added to each assay plate well and incubated for 2-4 h at 
37oC with 5% CO2.  Data were captured on a Molecular Devices SpectraMax M5 (excitation 
A560; emission A590).   
 
HTS data analysis and statistical analysis.  Primary HTS data analysis and subsequent 
compound IC50 calculations were performed using ActivityBase (IDBS, Guilford, UK) and 
Cytominer (University of Pittsburgh Drug Discovery Institute, Pittsburgh, PA).  Structural 
similarity of the confirmed inhibitors was determined using Leadscope software (Columbus, 
OH).  Additional visualization and statistical analysis were performed using GraphPad Prism 
software 5.0 and Spotfire (Somerville, MA).  The PubChem database 
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(http://PubChem.ncbi.nim.nih.gov) was used to verify if the confirmed TbHK1 small molecule 
inhibitors exhibited bioactivity in other assays. 
  
In silico ADME/Toxicity analysis.  Computational modeling tools were used to estimate the 
bioavailability, aqueous solubility, blood brain barrier potential, human intestinal absorption, the 
cytochrome P450 (i.e. CYP2D6) enzyme inhibition potential, mutagenicity, and hERG inhibition 
of the confirmed TbHK1 inhibitors. The bioavailability, aqueous solubility, and human intestinal 
absorption were estimated using the ADME Boxes v4.0 software (Pharma Algorithms, Toronto, 
Canada), while mutagenicity and hERG inhibition were estimated with TOX Boxes v2.9 
software (Pharma Algorithms, Toronto, Canada). The CYP2D6 inhibition and blood brain barrier 
potential were predicted using Accord for Excel 6.2.2 (Accelrys, Inc, San Diego).   
 
RESULTS 
Validation of optimized HTS assay conditions using the LOPAC set.  The TbHK1 coupled assay 
was optimized and validated for HTS by screening the LOPAC set.  Compounds were assayed in 
duplicate at a single concentration (10 µM) and reproducibility between the duplicate screens is 
represented in Fig. 1 (R2= 0.96).  Average Z-factors were 0.69 ± 0.02 for the two LOPAC assays 
demonstrating the robustness of the developed assay format [13].  Eighteen compounds inhibited 
TbHK1 enzymatic activity ≥ 40% at 10 µM including myricetin, a structural analog of quercetin, 
which was previously identified as a TbHK1 small molecule inhibitor (IC50 = ~85 µM) (Lyda 
and Morris, unpublished).  These data confirmed that our automated HTS assay conditions were 





Figure A.1.  Validation of the HTS by LOPAC screening.   
Plot of percent inhibition for duplicate screen of the 1280 LOPAC compounds.  LOPAC compounds 
(blue), minimum control, which should equal ~100% inhibition of signal readout (red), IC50 control 
compounds (yellow), and maximum control compounds, which should equal ~0% inhibition of signal 
readout (green), are indicated. 
 
Interrogation of 220,233 compounds for TbHK1 small molecule inhibitors.  We next screened 
220,223 compounds at a single concentration (10 µM) for small molecule inhibitors of TbHK1 
(Fig. 2).  The HTS assay performed robustly (average Z-factors of 0.80 ± 0.1) and identified 239 
compounds as primary actives (>50% inhibition at 10 µM), for an overall hit rate of 0.1%.  The 
239 active compounds were cherry-picked, and the initial inhibitory activity confirmed in the 
primary TbHK1 assay.  Additionally, the compounds were tested against the reporter enzyme, 
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G6PDH, to confirm that they did not interfere with the assay format.  Following initial 20 point 
IC50 value determinations using cherrypicked compounds, compounds with IC50 values < 50 µM 
were obtained from commercial sources.  The activity of the 13 resupplied compounds was 
empirically determined to control for possible TbHK1 inhibitory effects associated with 
compound library degradation.  Ten small molecules confirmed with TbHK1 IC50 values < 50 
µM while three compounds failed to inhibit TbHK1.  Leadscope analysis of the 10 confirmed 
TbHK1 inhibitors classified six compounds into a cluster of structurally related compounds 
(cluster 1) while the remaining four compounds were classified as singletons (Table 1, Fig. 3).  
Ebselen (SID 856002) was the most potent compound in cluster 1 with an IC50=0.05 ± 0.03 µM.  
For the majority of the compounds IC50 values either improved or remained similar to cherry-
picked compounds with the exceptions of SID 17386310 and SID 14728414 (Table 1) which 
were 7.5 and 6.6-fold less potent, respectively, upon resupply (data not shown).  Moreover, all 
ten novel TbHK1 inhibitors were 20-17,000-fold more potent than londiamine, a previously 
















Figure A.3.  Structures of HTS Cluster 1 and Singleton Hits  
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Additional experiments to assess the in vitro specificity included testing the compounds 
against hGlk.  The activity against hGlck was varied, with the cluster 1 compounds yielding a 
spectrum of efficacy, from very low inhibition at 10 µM (for example, SID 17387000, with 6.7% 
inhibition, Table 1) to near complete inhibition by ebselen (97.8% inhibition).  Singletons also 
demonstrated a spectrum of activity against hGlck with SID 22401406 and SID 14728414 
having minimal impact on the enzyme while 17386310 was a more potent inhibitor (Table 1).  
Moreover, data mining of the PubChem database (http://pubchem.ncbi.nlm.nih.gov/) determined 
the frequency with which a compound was found to be active in other assays.  In general, the 
cluster 1 compounds were active in other assays more frequently than the singletons, with SID 
17387000 the most frequently active (identified in 7.2% of the 238 assays in which it was 
tested).  Singletons, on the other hand, were less frequently active.  For example, SID 14728414 
was confirmed as an active in one of 216 assays (<1%) (Table 1). 
 
TbHK1 small molecule inhibitors are toxic to BSF parasites.  TbHK1 has previously been shown 
to be an essential gene for BSF T. brucei [4], suggesting that inhibitors of the enzyme may be 
promising lead compounds for therapeutic development.  To initially explore this possibility, we 
grew cultured BSF parasites in the presence of 10 µM compound and cell density monitored 
after 72 hr (Table 1).  The ten resupplied compounds were tested in this assay, with EC50s 
determined for those that inhibited cell growth >50% at 10 µM (Table 1). Compounds in cluster 
1 included two of the most potent anti-trypanosomal compounds, SID 17387000 and SID 
24785302.  Singletons were also toxic, with SID 17386310 being one of the most potent 
compounds tested to date.  Four molecules, including a member of cluster 1 (SID 3716597) and 
three singletons (SID 22401406, SID 24797131, SID 14728414) inhibited TbHK1 but were not 
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toxic to BSF at 10 µM.  With the exception of ebselen, the resupplied anti-parasitic compounds 
exhibited EC50 values that were 10-1000 fold lower than the TbHK1 IC50 values.  This 
discrepancy could result from other actions or concentration of the inhibitors in the glycosome, 
which is a small peroxisome-like organelle where TbHK1 is located.  Additionally, we have 
found that RNAi of TbHK1, which reduces expression but does not necessarily ablate it, is toxic 
to BSF parasites, suggesting that modest inhibition of cellular TbHK1 activity could be lethal to 
the parasite [4].  
To explore the likelihood of off-target whole parasite effects, we assessed the toxicity of 
the TbHK1 inhibitors against PF parasites.  Unlike BSF parasites, PF parasites can utilize both 
amino acids and glucose for ATP production.  This dynamic metabolism suggests that the PF 
parasites may be less sensitive to TbHK1 inhibitors.  Indeed, at 10 µM most of the resupplied 
compounds had only a modest impact on PF parasite growth, inhibiting growth between 0-51% 
when compared to control cell lines.  Compounds toxic to T. brucei were also assayed against a 
related kinetoplastid parasite, Leishmania.  The Leishmania promastigotes were typically less 
sensitive to the resupplied compounds (with EC50s >12.5 µM), with the exception of the cluster 1 
compounds ebselen, SID 17387000, SID 24785302 and the singleton, SID 17386310.  These 
compounds had EC50 values against Leishmania between 1-5 µM in exponentially growing 
parasites (Table 1).  Moreover, our identified TbHK1 inhibitors have minimal impact on human 
cell lines with EC50 values >12.5 µM, suggesting at least 400-fold greater toxicity toward 
















% Inhibition of 
hGlck (10 µM) 
BSF 
EC50 (µM) 
% PF Growth 
Inhibition (10 µM) 
L. major  
EC50 (µM) 
Cluster 1 856002 
(Ebselen) 
344/44/22 0.05 ± 0.03 97.8 ± 0.1 2.9 ± 0.28 51 ± 0.16 4.1 ± 0.4 
 17387000 236/38/17 2.0 ± 0.5 6.7 ± 9.4 0.030 ± 0.067 48 ± 0.15 1.9 ± 0.2 
 24785302 170/21/11 4.2 ± 1.0 6.9 ± 4.2 0.042 ± 0.0028 47 ± 0.15 1.9 ± 0.2 
 3716597 318/29/18 9.3 ± 0.3 7.8 ± 7.1 > 10 27 ± 0.080 >12.5 
 24830882 171/12/7 16.9 ± 0.1 88.8 ± 4.9 0.83 ± 0.20 8.6 ± 0.030 >12.5 
 16952891 214/24/11 2.6 ± 0.2 44.9 ± 9.9 0.30 ± 0.079 47 ± 0.15 >12.5 
Singletons 22401406 184/5/2 2.3 ± 0.3 0.0  > 10 0.0 >12.5 
 24797131 175/6/2 11.4 ± 3.2 6.3 ± 8.8 > 10 0.0 >12.5 
 17386310 211/10/4 33.6 ± 10.2 70.3 ± 3.6 0.038 ± 0.0038 50 ± 0.15 2.6 ± 0.1 
 14728414 216/2/1 41.7 ± 3.0 1.9 ± 7.0 > 10 0.0 >12.5 
1As of 09/03/09.  Number of bioassays in which the compound was 
tested/number in which the compound was active/number in which the 
compound has been confirmed as an inhibitor. 
 
In silico predictions for the identified TbHK1 inhibitors.  To investigate the chemical similarity 
of our newly identified TbHK1 small molecule inhibitors to current treatments for African 
sleeping sickness as well as previously described TbHK1 inhibitors, we performed a similarity 
search using the Tanimoto coefficient.  The data indicated that the TbHK1 inhibitors displayed 
low levels of similarity with all compounds examined with the highest similarity being between 
lonidamine and SID 16952891 (47%) (Table A.2).  Thus, these results demonstrate that the 
newly identified TbHK1 inhibitors are unique, either displaying no or very low similarity to 







Table A.2.  Comparison of structural similarities of HTS hits to licensed compounds used 
against HAT and to known TbHK1 inhibitors 








Accumulation in the mitochondria, 
DNA binding 
17386310  31 
Suramin 
 
Inhibition of glycolysis 24830882  38 
  24797131  38 
Melarsoprol 
 







Polyamine biosynthesis (via 
inhibition of ODC) 
14728414  27 
Lonidamine 
 
TbHK1 inhibitor3 16952891 
 
47 
Quercetin TbHK1 inhibitor4  24797131  38 
1Reviewed in (13). 
2Similarity coefficient was determined using the Tanimoto coefficient.  Compounds with values greater than 80% 
are considered highly structurally similar. 
3(4) 
4Lyda and Morris, unpublished 
 
Additional in silico ADME-tox predictions indicated that all ten TbHK1 compounds had 
an extremely low probability for being either a hERG channel inhibitor or mutagenic (data not 
shown).  Moreover, all compounds, except SID 3716597 were predicted to be moderately to 
highly bioavailable and nine of 10 compounds displayed medium to very high blood brain barrier 
(BBB) potential, with the majority of the cluster one compounds predicted to have high to very 
high BBB potential (Table A.3).  Six of 10 TbHK1 inhibitors were predicted to have no 
inhibitory activity on CYP2D6 enzyme with the exceptions being cluster one compounds SID 
3716597 and SID 24785301 and singletons SID 14728414 and SID 24797131 (Table 3).  The 
majority of the compounds had a predicted low aqueous solubility (Table 3), suggesting that if 
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these compounds were to be used in future analogue development, they would need to be refined 
to improve their aqueous solubility.  Thus, based on empirically derived data and in silico 
analyses, we focused on cluster 1 compounds for subsequent analyses.  
 
Table A. 3.  In silico ADME/Toxicity Analysis 
Leadscope 
Grouping 
PubChem SID Aqueous Solubility Bioavailability CYP2D6 inhibition Blood brain 
barrier 
Cluster 1 856002 
(Ebselen) 
Low High Non-inhibitor High 
 17387000 Low High Non-inhibitor High 
 24785302 Low Moderate Inhibitor Very High 
 3716597 Low Low Inhibitor Medium 
 24830882 Good High Non-inhibitor High 
 16952891 Low Moderate Non-inhibitor Medium 
Singletons 22401406 Extremely Low Moderate Non-inhibitor Undefined 
 24797131 Good High Inhibitor Medium 
 17386310 Good Moderate Non-inhibitor Medium 
 14728414 Low Moderate Inhibitor High 
 
 
Further characterization of two structurally related cluster 1 TbHK1 small molecule 
inhibitors.  Ebselen, 2-phenyl-1,2-benzisoselenazol-3(2H)-one, was the most potent TbHK1 
inhibitor (IC50 = 0.05 ± 0.03 µM) identified in our studies while  the structurally related inhibitor 
SID 17387000 (2-phenyl-1,2-benzisothiazol-3(2H)-one) was the next potent compound 
identified with an IC50 = 2.0 ± 0.5 µM (Table 1).  Analysis of the nature of TbHK1 inhibition 
revealed that both ebselen and SID 17387000 were mixed inhibitors with respect to ATP, with Ki 
values of 6.13 µM and 6.89 µM, respectively (Fig. 4).  However, both ebselen and SID 
17387000 exhibited comparable IC50 values against T. brucei lysate-derived TbHK1 enzymatic 
activity with IC50 values of 0.43 ± 0.02 µM and 1.2 ± 0.12 µM respectively (Fig. 5).  Thus, while 
compound SID 17387000 was nearly as potent against lysate activity as the bacterially expressed 
protein, ebselen was significantly less potent against parasite lysate-derived TbHK1 activity 
(than the bacterially expressed protein).  These results suggest that ebselen may be metabolized 
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by cellular components or that lysate-derived TbHK1 may be associated with various cofactors 
that result in less potent IC50 values.  Ebselen was also a potent inhibitor of hGlck (97.8% 
inhibition at 10 µM), while SID 17387000 had relatively little activity (6.7% inhibition) against 
the kinase (Table 1).  Moreover, ebselen was ~100-fold less active against BSF parasites (Table 
1).  Taken together, these data suggest that the subtle structural differences between the two 
compounds result in remarkable changes in their pharmacological behavior.  
 Both ebselen and SID 17387000 are potent trypanocides, with EC50s of 2.9 ± 0.28 µM 
and 0.030 ± 0.067 µM, respectively.  To determine if indeed the toxicity to BSF parasites is 
related to inhibition of cellular TbHK1, we measured the impact of the compounds on cellular 
G6P levels after culturing the parasites in the presence of ebselen and SID 17387000 [14] (Fig. 
5C).  To reduce the likelihood that toxicity was impacting G6P levels non-specifically, we 
limited the incubation period to 1 and 4 hours, while employing high doses (10 times the EC50) 
of the compounds.  Incubation with ebselen for either 1 or 4 hours led to a 56% or 70% reduction 
in G6P, while SID 17387000 was less effective, reducing G6P levels 29% and 18% after 1 and 4 
hours, respectively (Fig. 5C).  While these observations suggest a direct impact on TbHK 





Figure A.4.  Ebselen and SID 17387000 are mixed inhibitors of TbHK1 with respect to ATP.  
Lineweaver-Burk plots of inhibition with ebselen (A.) or SID 17387000 (B.).  Assays were performed as 







Figure A.5.  Ebselen and SID 17387000 inhibit TbHK activity from parasite cell lysate and cause a 
reduction in cellular G6P levels in BSF parasites.   
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Increasing amounts of (A.) ebselen or (B.) SID 17387000 were incubated with 2 x 105 BSF cell 
equivalents for 15 min at RT and HK assays were performed as described in the Materials and Methods.  
(C.) Growth in the presence of Ebselen or SID 17387000 causes a reduction in cellular G6P levels.  BSF 
parasites (1 x 107) were cultured for 1 or 4 hours in the presence of 30 µM or 1 µM (10-fold the EC50) 
ebselen or SID 17387000 followed by lysate preparation and comparison of G6P levels to an equivalent 
number of untreated parasites [14]. 
 
DISCUSSION 
There are currently four drugs approved for treatment of HAT.  However, suramin and 
pentamidine, developed in 1921 and 1941, respectively, are not effective against the late stage of 
disease that occurs when the parasite crosses the blood-brain barrier.  Melarsoprol, which was 
introduced in 1949, leads to fatal complications in 5-10% of patients receiving the drug [15].  
The most recently developed drug, eflornithine, is only efficacious against T. b. gambiense, but 
is curative for both the early blood-borne infection and the late stage of disease with central 
nervous system involvement; delivery of eflornithine is difficult, as the compound must be 
administered intravenously four times a day for 14 days (delivering ~360 g/patient).   
 A number of screens of chemical libraries have been undertaken to identify therapeutic 
leads against the African trypanosome.  These include a phenotypic screen that interrogated a 
library of FDA-approved drugs for anti-trypanosomal activity [16], as well as screens developed 
to identify inhibitors of essential parasite enzymes.  A screen for UDP-Glc 4’-epimerase 
inhibitors using a small natural products library [17] and a screen of a commercial 134,500 
compound library for trypanothione reductase inhibitors [18] are two examples of target-based 
screens used to identify lead compounds for therapeutic development. In the last few years, 
TbHK inhibitors have been explored as potential anti-parasitic compounds.  Previous efforts to 
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identify TbHK inhibitors include the development of compounds based on models of the TbHK 
structure (predicted from homology studies of the yeast structure), and exploring the activity of 
HK inhibitors from other systems [4].  Here we have used a HTS of 220,223 compounds to 
identify new inhibitors of the parasite enzyme.   
In our screens, we have identified several novel inhibitors of TbHK1.  One compound, 
ebselen, was the most potent inhibitor from both the LOPAC validation screen and the HTS.  
Ebselen is a lipid-soluble seleno-organic compound that has been employed in clinical trials to 
assess its value in prevention of ischemic damage in brain hemorrhage and stroke [19,20].  
Ebselen inhibits lipid peroxidation through a glutathione peroxidase-like action [21], but may act 
through other mechanisms as well.  Notably, a single oral dose (100 mg/kg) of ebselen yields 
serum values of 4-5 µM [22] and brain levels of the drug reach 21% of plasma levels [23], 
suggesting that the compound (or its derivatives) may be useful for both early and late stage 
sleeping sickness therapy development.   
Ebselen likely has polypharmacological effects on BSF parasites, as the compound is 
known to inhibit a number of enzymes in addition to TbHK1, including the trypanosome UDP-
Glc 4’-epimerase [17].  Ebselen, unlike other cluster 1 compounds, has an IC50 that is 
significantly lower than the EC50, suggesting its metabolism may be distinct from the sulfur-
bearing compounds.  Alternatively, a cellular “sink” could be interacting with ebselen, thereby 
lowering its effective concentration. 
The remaining cluster 1 compounds have EC50s notably lower than their TbHK1 IC50s, 
suggesting possible actions on other cellular targets.  Alternatively, differences between the two 
values could result from the concentration of the compound within the parasite (perhaps in the 
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glycosome) or metabolism of the inhibitor to a more potent form.  These hypotheses would seem 
worthy of further investigation. 
 An ideal therapeutic drug for African sleeping sickness would target the parasite (while 
perhaps enhancing host immune responses) and work at concentrations low enough to limit the 
severity of side effects.  In the search for potential drug targets, we have focused on the 
trypanosome TbHK1, a protein that the parasite requires to make ATP and have identified 
compounds that may serve as leads in for the development of therapeutics in the continuing fight 
against the African trypanosome. 
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